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ABSTRACT 
Background: Enteral nutrition is one method of delivering nutrition to 
intubated patients. There are several issues that prevent optimal delivery of the 
prescribed enteral nutrition goal rates. The measurement of the patient‟s gastric 
residual volume (GRV) may demonstrate tolerability, or intolerability, of 
enteral nutrition. Identifying a safe GRV, at which to accept and continue 
enteral nutrition delivery, is essential to ensure the delivery of enteral nutrition 
adequately achieves the nutritional requirements of patients, and to mitigate the 
risks associated with the delivery of enteral nutrition. 
 
Objectives: This systematic review sought to answer the research question: 
what is the maximum GRV to accept in order to continue the delivery of 
enteral nutrition in the Intensive Care Unit (ICU) adult patient? This is 
specifically related to the primary outcome measures indicative of accepting a 
specified GRV that is too high or too low. Accepting a GRV that is too high 
would put the patient at risk of vomiting, regurgitation, aspiration of gastric 
contents and potentially aspiration pneumonia. Conversely, accepting a GRV 
that is too low would put the patient at risk of not achieving caloric needs, 
potentially placing the patient at risk of malnutrition and increased morbidity.  
 
Search methods: Databases searched included: CCTR, CLCMR, CLTA, 
CLEED, OVID MEDLINE (R) (Ovid SP), EMBASE, CINAHL Plus with Full 
Text (EBSCO host via helicon), AMED, Ovid Nursing Full Text plus, CDSR, 
ACP Journal Club, DARE, Proquest via helicon (advanced search), Pubmed 
via helicon (limits “all adult”, “humans”, “abstract”, “title”), all EBM reviews, 
and the reference lists of articles. 
 
Selection criteria: The types of studies eligible for inclusion were published 
randomised controlled trials, case controlled studies, cohort studies and 
observational studies. Interventions considered were a comparison of two or 
more GRV measures. The participants eligible were adult ICU or critical care 
patients receiving enteral nutrition. The primary outcome measures for study 
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inclusion were caloric requirement met, and specified potential adverse events 
including vomiting, regurgitation, or aspiration. 
 
Data collection and analysis: Data was extracted using a data extraction tool 
created by the researcher. Risk of bias was assessed by the author using two 
risk of bias assessment tools. 
 
Main results: Three studies met the inclusion criteria for the systematic review 
(McClave et al., 2005; Metheny, Schallom, Oliver, & Clouse, 2008; Pinilla, 
Samphire, Arnold, Liu, & Thiessen, 2001). Each of these studies contained 
methodological risks of bias and limitations related to their study designs. 
McClave et al.‟s study was a prospective study (n = 40), Metheny et al.‟s study 
was a prospective descriptive study (n = 206), and Pinilla et al.‟s study was a 
randomised controlled trial (n = 80). No one study, or a combination of studies, 
provided conclusive evidence to support the use of one particular GRV over 
another. 
 
Author’s conclusion: No recommendation for a definitive GRV was made in 
this systematic review due to the lack of strong evidentiary support for one 
GRV over another. There remain opportunities for enhancing practice through 
developing a consistent, multidisciplinary approach to managing GRVs. There 
are future research opportunities related to improving the management of 
GRVs in the enterally fed ICU patient, and achieving optimal volumes of 
nutrition delivered. 
 
Key words: nursing practice, enteral nutrition, gastric residual volumes, 
intensive care, systematic review.  
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GLOSSARY OF TERMS 
 
Term Definition 
Algorithm Provides a summary of guideline recommendations 
in the form of a flow chart, with linked process steps 
and decision points (New Zealand Guidelines Group, 
2001). 
Enteral nutrition The delivery of nutritional support directly into the 
gut via a tube (National Institute for Health & 
Clinical Excellence, 2006). Enteral nutrition is a 
form of nutrients that can be administered via a tube 
directly to the stomach. This tube may extend from 
the nose or the mouth, and pass directly to the 
stomach (naso-gastric or oro-gastric); or may pass 
beyond the stomach (postpyloric) to the jejunum or 
duodenum (naso-jejunal or naso-duodenal); or may 
be percutaneously placed, using an endoscope, 
directly through the abdominal wall to the stomach 
or jejunum (percutaneous endoscopic gastrostomy or 
percutaneous endoscopic jejunostomy) (Urden, 
Stacy, & Lough, 2006). 
Forest plot A geographical plot of each of the studies combined 
in a meta-analysis, usually depicted as a square for 
each study result, with the confidence interval 
illustrated by a line passing through the square. The 
combined results of all studies are plotted graphically 
at the bottom of the plot by a diamond with the 
horizontal corners of the diamond illustrating the 
confidence interval. A diamond clear of the line of 
no effect shows significance (Lewis & Clarke, 2001).  
Funnel plot A graphical plot of effect estimates against sample 
size to assess validity of meta-analyses. Based on the 
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Term Definition 
assumption that accuracy is directly related to sample 
size. Skewed or asymmetrical funnel plots suggest 
bias, and symmetry suggests absence of bias (Egger, 
Smith, Schneider, & Minder, 1997). 
Gastric residual 
volume or gastric 
aspirate volume 
A volume obtained by aspirating (withdrawing) the 
stomach contents via the gastric tube. During 
intragastric feeding, the gastric volume includes the 
amount of nutrition delivered and the endogenous 
secretions (Metheny, Schallom, & Edwards, 2004). 
Malnutrition Malnutrition is a pathological state caused by relative 
or absolute deficiency of one or more essential 
nutrients (Atkinson & Worthley, 2003). Malnutrition 
in the critically ill has been defined as a disorder of 
body composition whereby nutrient deficiencies 
occur when required nutrition is not met causing 
reduced organ function, altered blood chemistry 
studies, reduced body mass and sub-optimal clinical 
outcomes (Cerra et al., 1997). This may be measured 
through history taking, physical examination and 
nutritional assessment indices (Atkinson & 
Worthley, 2003). The most common cause of 
malnutrition is inadequate nutritional intake as a 
result of reduced intake, increased requirements or 
impaired ability to absorb or use the nutrients 
(Stratton, 2007).  
Nutrition Nutrition provides the carbohydrate, lipid, amino 
acids, water, vitamins and minerals required for 
growth, development and the maintenance of 
physiological and bodily functions in the human 
body. Nutrition may be provided by diet, which 
requires active participation to meet their nutritional 
needs, or by nutrition support, which is delivered 
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Term Definition 
nutrition that bypasses the patient‟s active 
participatory responses (Case, Cuddy, & Dooling-
McGurk, 2000). In normal nutrition there is an 
alternate state of feeding and fasting (Atkinson & 
Worthley, 2003). Feeding increases glycogen 
reserves and protein synthesis; fasting reduces 
insulin secretion and increases glucagon secretion. 
After hepatic glycogen is depleted, body protein is 
used to meet glucose demands. Fasting for longer 
than 72hrs induces a state of starvation (Atkinson & 
Worthley, 2003). 
Optimal nutrition Sufficient intake of nutrients to support the metabolic 
requirements of the body (Jarvis, 2003). 
Overnutrition Excessive intake of nutrients, surplus to the 
requirements of the body (Jarvis, 2003). The impact 
of overfeeding total calories may cause exacerbation 
of hyperglycemia, fatty liver, increased CO2 
production, and an increased amount of energy 
expenditure to manage excessive caloric loading 
(Parrish & McCray, 1999). 
Parenteral nutrition The delivery of nutrition support intravenously 
(Leonard, 2009). 
Pulmonary aspiration Pulmonary aspiration is the passage of foreign 
material into, and distal to, the trachea. One example 
of a foreign material may be regurgitated gastric 
contents. The gastric acid in these gastric contents 
damages the alveolar and capillary endothelial cells, 
consequentially protein rich fluid leaks into the 
interstitum and alveoli causing atelectasis and 
consolidation (Urden et al., 2006). 
Refeeding syndrome Commencing a normal volume of nutrition following 
a period of starvation may result in refeeding 
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Term Definition 
syndrome. This is associated with serum electrolyte 
disturbances including hypophosphataemia, 
hypokalaemia and hypomagnesaemia. Rebound 
effects may manifest as cardiac and respiratory 
failure, paraesthesia and seizures (Leonard, 2003). 
Regurgitation The appearance of digestive fluid into the 
oropharynx (Desachy et al., 2008). 
Undernutrition Insufficient nutritional intake to maintain adequate 
nutritional reserves or to meet the metabolic 
requirements of the body (Jarvis, 2003). 
 
  
 
 
CHAPTER 1 INTRODUCTION 
 
Engaging in evidence-based and collaborative critical care nursing to achieve 
optimal outcomes for patients poses a significant challenge in the Intensive 
Care Unit (ICU). Clinical questions are identified on a daily basis when 
providing and facilitating high quality nursing care. Some of these are 
answered easily by expert clinicians and the multidisciplinary team (MDT) and 
are informed by existing knowledge bases. Other questions are complex, 
multidisciplinary and not so easily answered. In these cases, research may be 
required to address these questions. The clinical question at the forefront of this 
research project is both complex and multidisciplinary. This systematic review 
sought to answer the research question: what is the maximum GRV to accept 
and continue the delivery of enteral nutrition in the ICU adult patient? 
 
Context 
 
I (the researcher) am a registered nurse (RN) employed in an ICU of a New 
Zealand tertiary hospital. During one shift a colleague was caring for a patient 
who had a nasogastric tube and was being enterally fed (nutrition delivered via 
the gastric tube). The current local protocol and policy which informs the ICU 
nurse‟s management of enteral nutrition includes aspirating the gastric tube to 
measure the residual volume in a patient‟s stomach every four hours. There is 
also a directive, within this protocol, related to the process to follow depending 
on the volume of gastric residual obtained. This indicates how much aspirate to 
return, and how to manage the infusion rate of the enteral nutrition. 
 
My nursing colleague identified a concern when conducting gastric residual 
aspiration on an enterally fed ICU patient (note: the term „ICU patient‟ has 
been used synonymously with the terms „critical care patient‟ and „critically ill 
patient‟). The concern was that the gastric residual volume (GRV) aspirated 
was over 300mL. The volume was considered to be a large amount by this 
nurse. The nurse was concerned that with such a high GRV, the patient might 
be at risk of vomiting and aspirating their gastric contents. These concerns 
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were informally discussed amongst the nursing and medical staff available 
during the shift, related to what they would do with that GRV in order to 
clinically manage this patient. There were various responses, which 
demonstrated several different interpretations of the existing enteral nutrition 
protocol and policy. This provoked a review of the 1998 policy related to 
enteral feeding in the adult intensive care patient, encompassing the 10 year 
period from 1998 to 2008. 
 
Involving the local stakeholders 
 
As part of the review of the enteral nutrition policy, the clinical question 
regarding the management of GRVs led to the sourcing of literature. This 
literature search incorporated the nursing management of GRVs and enteral 
nutrition in the intensive care unit, with a timeframe of 1998 to 2008. It was 
anticipated by the researcher that since 1998 there would be evidence from 
research to inform practice and improve the evidence-base to the existing 
policy. A MDT (dietetics, doctors and nurses) meeting was arranged to discuss 
the existing policy and the review of this literature. The existing policy 
encompassed a broad range of management strategies related to the delivery of 
enteral nutrition including: indications and contraindications, safety 
considerations, and a procedural guide to the safe delivery of enteral nutrition. 
One aspect of the policy was an algorithm providing specific guidance on the 
management of GRVs. 
 
The agenda of the MDT meeting focussed on the components of the algorithm 
related to the management of GRVs. What was discovered was that the most 
appropriate management strategy surrounding GRVs was contentious. The 
MDT identified the GRV as one method of assessing if the patient was 
tolerating the infusion of nutrients, or was at risk of vomiting or regurgitating 
and potentially aspirating gastric contents. The MDT agreed that a specific 
volume would be appropriate to include in an enteral nutrition management 
algorithm, however identifying the critical numerical GRV to use highlighted 
the inconsistencies both within and between disciplines. The questions that 
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arose were, what critical volume could be used in the algorithm as the volume 
of gastric aspirate that would lead nurses to either continue delivering, or 
potentially increase the infusion rate towards a goal rate of enteral nutrition? 
Alternatively, what critical volume could be used to lead nurses to either cease 
or reduce the infusion rate of enteral nutrition if it was less than that critical 
volume? Different MDT professionals, both within and between disciplines, 
identified different critical volumes, based on their experiences, the available 
guidelines and recommendations they had seen, current practice management 
strategies and protocols, and personal opinion. 
 
There were specific patient-related factors that influenced both the practice and 
the recommendations of members of the MDT. Further discussion related to 
these factors highlighted that most clinicians feared patients would regurgitate 
and aspirate gastric contents, potentially causing aspiration pneumonia during 
enteral nutrition delivery. Or alternatively, that patients receiving enteral 
nutrition would not receive adequate nutrients. What was clear from these 
MDT discussions was that further research would be required to complete the 
policy review. 
 
Research method 
 
No formal literature review process had been adopted to retrieve the articles on 
which the MDT meeting discussions were based. For example, there was no 
documented search strategy, nor was the quality of the studies appraised. 
Furthermore, outcome measures associated with the individual studies were not 
considered. The literature sourced for the policy review and algorithm 
development was not sufficient to generate a practice change, or to enable 
completion of the policy review related to the management of GRVs. It became 
apparent that a more robust method of extracting evidence would be required. 
Planning was then commenced to identify the most appropriate research 
method to answer the clinical question raised. A systematic review was 
considered in further detail, and decided upon by the researcher as the optimal 
way of addressing this clinical question more rigorously and systematically, in 
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an effort to enhance the management of GRVs in the enterally fed adult ICU 
patient. 
Beneficiaries 
 
The cornerstones of this research project, and those that will benefit most from 
answering this clinical question, are the ICU patients. This thesis seeks to 
enhance the standard of care in the management of enteral nutrition delivery by 
identifying the best evidentiary GRV to use. The MDT involved in the delivery 
of enteral nutrition to the ICU patient will also benefit from clarification of 
management strategies related to GRVs in the provision of enteral nutrition. 
 
Thesis outline 
 
This thesis is presented in the form of seven chapters. Chapter one has 
provided an introduction to the systematic review, highlighting how the clinical 
question arose and why the research is required. The nurses‟ role in the 
assessment of GRVs is outlined. This positions the researcher and the principal 
beneficiaries in the context of the research project. 
 
Chapter two will identify and discuss the background to GRVs in the enterally 
fed adult patient in the ICU setting. Gastric residual volumes are introduced in 
the wider setting of nutrition and enteral nutrition. Existing literature, reviews, 
and clinical practice guidelines and recommendations that identify specific 
GRVs are summarised and critiqued. The connection of GRVs to nursing 
practice is addressed, particularly focusing on the contextual implications, and 
evaluating the role of systematic reviews in evidence-based nursing practice. 
The aim of this systematic review is introduced and the key objectives are 
outlined. The methodology for the systematic review is then discussed in 
Chapter three.  
 
The methodology of systematic review and a meta-analysis is presented in the 
context of evidence based practice. The systematic review and meta-analysis 
approaches and processes are outlined with a discussion of the Cochrane 
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methodology of systematic review. Two tools for the assessment of the risk of 
bias are introduced, and a method of assessing the level of quality of a body of 
evidence is identified. The data extraction process is included in a discussion 
related to the promotion of reliability and validity. This is followed by the 
method for the systematic review in Chapter four. 
 
The method chapter of this systematic review addresses the criteria for 
considering the studies for this review, including the types of studies, 
participants, interventions and outcome measures eligible for inclusion. The 
search method is defined for identification of the studies, and the method of 
data collection and analysis is described. Chapter five presents the results of 
the systematic review. 
 
The results provide a description of the studies, which includes both the 
characteristics of included and excluded studies. The included studies are then 
reviewed with respect to the study methodologies, participants and settings. 
The risk of bias is analysed using relevant risk of bias analysis tools. The 
effects of the comparative GRVs from the studies are described and these 
results are then discussed in Chapter six. 
 
The discussion provides a summary of the main results of the systematic 
review in light of the identified outcome measures and related literature. The 
quality of the evidence and the potential for bias within the systematic review 
is also considered. This chapter is followed by the conclusion. 
 
Chapter seven presents a concluding statement. This discusses the implications 
of the findings of this systematic review in relation to clinical practice. A 
strategy for the dissemination of the research implications is provided. Future 
research opportunities are presented. 
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CHAPTER 2 BACKGROUND 
The previous chapter has provided an introduction to the clinical context of this 
research thesis and the position of the researcher. Chapter two outlines the 
background to GRVs in the enterally fed adult patient in the ICU setting. 
Gastric residual volumes are introduced in the context of nutrition and enteral 
nutrition. The functional anatomy of the stomach is described and linked with 
the impact of critical illness. Achieving nutritional requirements is examined in 
relation to the role of enteral nutrition in maintaining gastric structure, 
function, and defence mechanisms. The role of GRVs as a measure of tolerance 
to enteral nutrition is considered, and literature that identifies specific GRVs is 
summarised and critiqued. The aim of the systematic review is introduced and 
the key objectives are outlined. 
 
Nutrition in critical care 
 
Nutrition is a key determinant of health and development (Ministry of Health 
& University of Auckland, 2003; World Health Organisation, 2009). The New 
Zealand Ministry of Health identified improving nutrition as one of their 13 
health priorities in the New Zealand Health Strategy (Ministry of Health, 
2007). Admission to hospital and into the unique environment of the ICU, 
requires alternative strategies to achieve optimal nutrition for patients (Kozier, 
Erb, Berman, & Burke, 2000). Nutritional support is a fundamental aspect of 
care in the critically ill (Kozier et al., 2000) and is now accepted standard 
practice (Leonard, 2009). 
 
Historically, the provision of nutrition has been considered as an adjunct to 
intervention, supporting the intensive care of a patient; more recently the 
provision of early nutritional support to the ICU patient has been repositioned 
as a therapeutic intervention (McClave & Heyland, 2005). The primary goal of 
the delivery of nutrition is to ensure adequate nutritional support for body 
requirements to minimise complications and support recovery, in particular 
when oral intake is insufficient or unsafe (National Institute for Health & 
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Clinical Excellence, 2006). Malnutrition in the critically ill patient may 
contribute to prolonged ventilation, and increased risks for infection and 
mortality (Hermsen et al., 2008; MacIntyre, 2001). The association of critical 
illness with hypermetabolism potentially exacerbates the likelihood of poor 
outcomes in inadequately nourished patients (Buckley & Kudsk, 1998). 
 
Sedation and ventilation of many ICU patients necessitates an alternative 
method to oral nutritional intake. Enteral nutrition is one option. Three 
methods for delivering enteral nutrition to the stomach are the administration 
via an orogastric tube (extends from the mouth to the stomach), a nasogastric 
tube (extends from the nose to the stomach), or a percutaneous endoscopic 
gastrostomy tube (passes percutaneously through the abdominal wall to the 
stomach) (Thomas & Bishop, 2007). In this systematic review, enteral nutrition 
is confined to the provision of continuous enteral nutrition to the stomach via 
one of these three types of gastric tubes. 
 
One method of assessing a patient‟s tolerance to enteral nutrition, frequently 
mentioned in the literature, is by intermittently measuring the residual volume 
of liquid contents in the stomach, known as the GRV (Metheny, 2008; Parrish 
& McClave, 2008). Measuring GRVs involves attaching a large syringe to the 
feeding tube and aspirating (drawing back on the syringe), to evaluate the 
volume of the remaining contents in the stomach (Arbogast, 2002). The GRV 
aspirated is then managed according to local practice, guidelines, protocol, or 
policy, and this may include the return of some, all, or none of the aspirated 
volume. A discussion of the functional anatomy of the stomach provides the 
foundations for further discussion of the use of GRVs during the delivery of 
enteral nutrition. 
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Functional anatomy of the stomach 
 
Physiology 
 
Anatomically, the hollow stomach can be differentiated into the cardia, fundus, 
gastric body, antrum and pylorus. Functionally, the proximal area provides a 
reservoir for a meal and distally there is an ability to generate contractions to 
mix, grind and empty the stomach of food (Tack, 2006). Circular, peristaltic 
waves assist this process distally by altering tonicity of the stomach. Duodenal 
contractions in the full duodenum delay further gastric emptying due to the 
reduced capacity of the duodenum (Tack). Movement through the small 
intestine to the colon for storage and elimination is dependent on effective 
motor function to facilitate mixing and propulsion (Hasler, 2006). The pancreas 
assists in the neutralising of the gastric secretions for duodenal digestion, 
alongside providing the enzymes and enzyme precursors required for this 
process (Gorelick & Jamieson, 2006). The stimulus for this secretory process is 
thought to be primarily associated with the ingestion, digestion and absorption 
of food (Gorelick & Jamieson). 
 
Gastric volumes and gastric emptying 
 
Normal gastric emptying for liquids is related to fundic pressure which 
increases with the infusion of a volume of liquid into the stomach (Parrish & 
McClave, 2008). This causes an initial rapid phase of emptying the stomach, 
this rate then slows to empty the remaining liquid. In a computer simulation 
model, Lin and Van Citters (1997) reported that 4000-5000mL of normal 
secretions pass through the stomach per day. The gastrointestinal tract is 
innervated extrinsically by the parasympathetic and sympathetic nervous 
systems in response to gastric distension, via mechanoreceptors, and gastric 
contents, via chemoreceptors (Shulkes, Baldwin, & Giraud, 2006). Vagal 
stimulation activates gastric secretion, motility and blood flow, sympathetic 
stimulation reduces gastric secretion and blood flow (Shulkes et al.). Thus, 
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blood flow is generally increased with gastric secretion, in response to 
histamine, gastrin and acetylcholine, but reduced by catecholamines, atropine 
and somatostatin. Consequently, maintenance of the structure and function of 
the stomach is fundamental to effective gastric emptying. 
 
The role of enteral nutrition in the stomach 
 
Enteral nutrition and maintaining structure and function 
 
Literature supports the use of enteral nutrition as a first choice in the 
administration of nutrition in the critical care setting, unless this was 
unavailable, impractical or unsafe (McClave & Heyland, 2005). They suggest 
that use of the gastrointestinal tract was fundamental following critical illness. 
McClave and Heyland also proposed that the provision of 50% to 60% of the 
caloric goal rate may be required to prevent the loss of both functional and 
structural integrity alongside modulating the systemic immune response. 
 
The maintenance of gastric function and structural integrity is important as it 
has been shown to reduce morbidity in ICU patients (Farber, Moses, & Korn, 
2005; MacKenzie, Zygun, Whitmore, Doig, & Hameed, 2005). Principally, the 
delivery of enteral nutrition involves the provision of sufficient energy and 
nutrients to facilitate normal physiological functions, such as body tissue 
growth, repair, replacement, and protection (Thomas & Bishop, 2007). 
Additionally, enteral nutrition has been found to have an essential role in 
maintaining the structure and function of the gastrointestinal mucosal barrier, 
promoting gut motility, and avoiding the infectious complications and costs 
associated with parenteral nutrition, which is an alternative method of nutrient 
delivery (Jolliet et al., 1998; Kudsk, 2001, 2002). These benefits primarily arise 
from the role of enteral nutrition in preventing mucosal atrophy through 
enhancing mucosal blood flow and the secretion of immunoglobulins and 
hormones (Jolliet et al., 1998; Peng, Yuan, & Xiao, 2001). Furthermore, 
maintenance of the structure and function of the stomach are essential for 
maintaining a system of defence. 
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Enteral nutrition and defence 
 
Research has demonstrated that the provision of enteral nutrition in the 
critically ill has benefits beyond those associated directly with adequate 
nutrition (Eckmann, 2006; Grant, 2006; Johansen et al., 2006; Kudsk, 2001, 
2002). The gastrointestinal tract‟s immune system has an innate ability to elicit 
antimicrobial activity through activation of molecules by enzymes. This ability 
is highly effective in infection control as a first line of defence (Eckmann). At 
the mucosal surface, immunoglobulins modulate this system of defence 
(Johansen et al.). The gastric mucosal surface protects the gastrointestinal tract 
against this acid and, the protein digesting enzyme, pepsin. Improved critical 
care management of patients with single organ failure has reduced mortality, 
but increased the risk of multiple organ dysfunction syndrome (C. Doig, 
Sutherland, Sandham, Verhoef, & Meddings, 1998). 
 
Doig et al.‟s (1998) prospective, observational cohort study compared 
intestinal permeability and the development of multiple organ dysfunction 
syndrome (MODS) in a group of critically ill ICU patients. In the healthy 
person, the intestinal epithelial barrier selectively enables the movement of 
molecules through the epithelium; however, Doig et al. found that patients who 
developed MODS had significantly worse intestinal permeability at admission 
than the non-MODS cohort. Damaged intestinal mucosa plays a key role in 
increased permeability (Johnson & Kudsk, 1999). Without adequate nutrition, 
the ability to mount an inflammatory response is diminished (Griffiths, 2007). 
Enteral stimulation enhances immune defences (Kudsk, 2001) and facilitates 
the hosts protection from bacteria and toxic products (Kudsk, 2002). It has also 
been suggested that commencing enteral nutrition may also restore intestinal 
anatomy and function (Grant, 2006). Initiating enteral nutrition early as a 
means to ameliorate septic complications is purported to be important. For 
example, a meta-analysis in 1992 highlighted the potential for early enteral 
nutrition to reduce the development of septic complications (Moore et al., 
1992). Furthermore, research on mice has demonstrated a reduced rate of death 
when subjects are enterally fed as opposed to parenterally fed (Fukatsu et al., 
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2001). What this research highlights is that enteral nutrition is essential to the 
promotion of health in the critically ill patient and thus, ensuring the effective 
and adequate delivery of this critical component of intensive care is crucial. 
 
The impact of critical illness on the gastrointestinal 
system 
 
Reduced gastric motility 
 
Critical illness has been associated with reduced gastric motility (Dive, 
Moulart, Jonard, Jamart, & Mahieu, 1994; Gue, 2006). Stress alters 
gastrointestinal motor function and gut motility, particularly inhibiting gastric 
emptying (Gue). The critically ill mechanically ventilated patient has less 
peristaltic activity, particularly in the stomach, compared to that of healthy 
individuals (Dive et al.). A literature review addressing aspects of critical 
illness that impact on gastrointestinal motility discussed the impact of both 
acute illness and therapeutic interventions such as opioids, β-adrenergic 
blockers, and anticholinergic drugs (Fruhwald, Holzer, & Metzler, 2008). 
Several factors that reduce the natural defence mechanisms of the 
gastrointestinal tract were discussed, including abdominal surgery, 
haemodynamic instability, fluid and electrolyte alterations, vasoactive 
medication, sedation and analgesia. The provision of enteral nutrition to 
ameliorate the impact of these has been purported, however patients would 
require adequate intestinal motility (Fruhwald et al.). One method of promoting 
intestinal motility is the administration of prokinetics to facilitate gastric 
emptying (Deane, Fraser, & Chapman, 2009). 
 
Potential for aspiration 
 
Critical illness has also been linked with the aspiration of gastric contents 
(Bullock, Waltrip, Price, & Galandiuk, 2004; Elpern, 1997; Grant, 2006). This 
risk for aspiration has been associated with the intubated patient who has a 
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naso- or oro-gastric tube, and also with the head-injured patient who has 
reduced oesophageal sphincter pressure, particularly in those patients with 
delayed gastric emptying reflected in elevated GRVs. In the intubated patient, 
the endotracheal tube stents the glottis open, and if a naso- or oro-gastric tube 
is present this stents the oesophageal sphincter open. This may predispose the 
intubated and enterally fed patient to aspiration (Bullock et al.). Gastric 
distension may result in gastroesophageal reflux and ultimately pulmonary 
aspiration (Grant). Despite the use of cuffed endotracheal tubes, these do not 
reliably prevent aspiration of substances into the lower airway (Elpern). 
 
Improving the delivery of enteral nutrition 
 
In an effort to mitigate the potential risks associated with delivering enteral 
nutrition, standardisation of practice has been proposed as one method to 
improve the management of enteral nutrition. Many critically ill patients do not 
meet their nutritional goals, which has been linked to inconsistencies related to 
enteral nutrition practices both within and between ICUs (Marshall & West, 
2004). The lack of reliable and valid research related to the effective delivery 
of enteral nutrition, may mean that there is a reliance on largely unchallenged 
tradition and rituals (Marshall & West). Marshall and West identified that the 
strategies for the management of enteral nutrition may result in insufficient 
delivery of feed. For the ICU patient, one of the most frequently reported 
reasons for discontinuation or inadequate delivery of enteral nutrition is high 
GRVs (Bourgault, Ipe, Weaver, Swartz, & O'Dea, 2007; McClave et al., 1999; 
Roberts, Kennerly, Keane, & George, 2003). 
 
Evidence-based guidance 
 
The effective use of an algorithm has been shown to improve the delivery of 
prescribed enteral nutrition rates (Adam & Batson, 1997; Bowman et al., 2005; 
Mackenzie, Zygun, & Hameed, 2003; MacKenzie et al., 2005; Martin, Doig, 
Heyland, & Sibbald, 2004; McClave & Snider, 2002). Martin et al. (2004) 
conducted a multicentre, cluster-randomised clinical trial in Canadian ICUs,  
29 
 
and concluded that there was improved provision of nutritional support and 
clinical outcomes with the implementation of evidence-based 
recommendations. Martin et al.‟s findings were consistent with other studies 
which identified that evidence-based nutritional support protocols improved the 
delivery of enteral nutrition (Adam & Batson, 1997; MacKenzie et al., 2005) 
and increased the frequency of goal rates being achieved whilst decreasing the 
reports of aspiration pneumonia and ventilator-associated pneumonia (Bowman 
et al., 2005). What these studies highlight is that having a protocol or algorithm 
to guide enteral nutrition delivery is of benefit. However, a rigorous evidence-
base to the components of the protocol or algorithm, for example the process 
guiding GRV management, is essential. 
 
Mitigating risk through the use of an algorithm 
 
Using an evidence-based algorithm in the management of GRVs seeks to 
mitigate two of the issues of most concern in GRV management. This is related 
to the practice of accepting a GRV that is either too high or too low. Accepting 
a GRV that is too high may predispose a patient to gastroesophageal reflux, 
and potentially aspiration (Metheny et al., 2004). Furthermore, the stomach has 
previously been identified as a source of bacteria for colonising the trachea in 
the mechanically ventilated critical care patient (Pingleton, Hinthorn, & Liu, 
1986; Tryba, 1991). The impact of accepting a GRV that is too low may 
influence whether a patient‟s nutritional requirements are adequately met. Both 
of these scenarios, either the delivery of too much nutrition (overfeeding), or 
too little nutrition (underfeeding), have been demonstrated to occur in the 
context of the ICU patient. 
 
Underfeeding was found to be common in ICU; in one study of 129 critically 
ill patients, 43% were found to be malnourished (Giner, Laviano, Meguid, & 
Gleason, 1996). These malnourished patients had a higher incidence of 
complications and fewer were discharged from the hospital. Underfeeding was 
associated with malnutrition, and overfeeding was associated with poor 
glycaemic control and impaired weaning from mechanical ventilation (Reid, 
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2006). Comparatively, overfeeding predominantly occurs when patients 
receive both an oral and enteral diet, and when patients are delivered a nutrient 
dense enteral formula (Reid, 2006). Nutrients are well matched to requirements 
of the immune response in the healthy person, but these are confounded by the 
inpatients variables of immobility and continuous nutrient delivery in the 
critically ill (Griffiths, 2007). This highlights the importance of facilitating the 
safe delivery of enteral nutrition, both to achieve caloric requirements and to 
mitigate a potential risk of aspiration.  
 
 Use of GRVs as a measure of patient tolerance of 
enteral nutrition 
 
Tolerance and intolerance of enteral nutrition in the critically ill patient has 
wide variation in definition. Indicators of intolerance to enteral nutrition have 
been defined as vomiting, abdominal distension, diarrhoea and high GRV 
(Kozar et al., 2002). The historical premise for measuring a GRV, as 
highlighted by McClave and Snider (2002), is that large residual volumes have 
been thought to indicate gastric intolerance to enteral feeding, a potential for 
vomiting and aspiration, and ultimately a risk for aspiration pneumonia. 
Conversely, based on these assumptions, low GRVs would suggest enteral 
nutrition tolerance and a minimal risk of aspiration (McClave & Snider). 
However, accepting a GRV too low may subject the patient to underfeeding, 
and hence their nutritional needs not being met. This potential may be 
exacerbated by not returning a GRV. One randomised, prospective, clinical 
trial of 125 critically ill patients supported the reintroduction of a GRV 
following measurement (Juve-Udina et al., 2009). The authors found that 
participants who had the GRV reintroduced had a lower incidence and severity 
of delayed gastric emptying episodes. The practice of measuring a GRV has 
experienced considerable debate related to the paucity of evidence, and 
abundance of assumptions, to support the relationship between elevated GRVs 
and enteral nutrition intolerance. 
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Assumptions 
 
Parrish and McClave (2008) suggest that the practice of assessing GRVs 
developed from a set of assumptions that reflect a paucity of scientific data. 
These assumptions include that: the practice of assessing GRVs will identify 
abnormal gastric emptying, elevated GRVs are a direct result of delayed gastric 
emptying, the measurement of a GRV may reflect retention of enteral formula, 
accumulation of enteral nutrition in the stomach leads to aspiration, and 
aspiration of gastric contents results in pneumonia. According to Parrish and 
McClave, the ultimate impact of these assumptions is that enteral nutrition is 
frequently discontinued inappropriately based on the practice of assessing 
GRVs. 
 
The underlying assumption that the stomach has a fixed volume capacity, and 
measurement of the volume of stomach contents enables prediction of potential 
overflow into the oesophagus and increased aspiration risk, has been dismissed 
as inherently flawed (McClave & Snider, 2002). This premise for aspiration 
risk assessment may be further undermined by Metheny et al.‟s (2008) 
descriptive study which found that of their 206 participants, 93% had at least 
one tracheal secretion positive for pepsin. This was deemed as a proxy for the 
aspiration of gastric contents by Metheny et al. Although this percentage of 
aspiration increased as GRVs increased, even patients who had a GRV between 
0-50mL had 34% positive pepsin assays (Metheny et al.). Furthermore, the 
assumption that enteral feeding intolerance leads to the development of 
pneumonia has also been questioned. For example, Umbrello, Elia, Destrebecq, 
and Iapichino‟s (2009) study of 78 ICU patients confirmed that the 
development of pneumonia was not associated with upper digestive 
intolerance. 
 
Despite these inherent flaws to the argument for using GRVs to inform 
management of enteral nutrition, GRV management algorithms remain 
abundant in practice (Bowman et al., 2005; Marshall & West, 2004). Other 
methods have been proposed in the literature as a measure to assess gastric 
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emptying including scintigraphy, the paracetamol
 
absorption test, breath tests, 
refractometry, ultrasound, and gastric
 
impedance monitoring (Moreira & 
McQuiggan, 2009). Moreira and McQuiggan‟s narrative review found 
refractometry to be the most appropriate of these methods. A refractometer 
measures the degree of light bending between substances of different densities 
(Chang, McClave, Hsieh, & Chao, 2007). Using the refractometer and a 
refractive index to measure gastric contents, Chang, McClave, Lee, and Chao 
(2004) raised the potential feasibility that refractometry may be a method of 
bedside monitoring of tolerance and gastric emptying to complement 
traditional GRV measurement (Chang et al., 2004). These proposed alternative 
evaluation methods require further validation in clinical practice, and until this 
validation occurs, GRVs remain the most common method of assessing gastric 
emptying. Hence, with the ongoing reliance on the aspirated GRVs to inform 
management of enteral nutrition, despite the lack of supporting research, 
ensuring the existing practices related to GRVs is evidence-based is crucial. 
 
Inconsistencies in the management of GRVs 
 
There are inconsistencies between accepted GRVs and management strategies 
related to the volume of gastric residual identified, both in the literature 
(Bourgault et al., 2007; Bowman et al., 2005; Cerra et al., 1997; Kattelmann et 
al., 2006; Keithley & Swanson, 2004; Marshall, 2005; McClave et al., 2002; 
McClave & Snider, 2002; Metheny, 2008; Parrish & McClave, 2008; Parrish & 
McCray, 2003; Pinilla et al., 2001; Zaloga, 2005), and in the recommendations 
of clinical practice guidelines (American Gastroenterological Association, 
1994; American Society for Parenteral and Enteral Nutrition Board of 
Directors & The Clinical Guidelines Task Force, 2002; Cerra et al., 1997; 
Critical Care Nutrition, 2007; Dietitians Association of Australia Nutrition 
Support Interest Group, 2007; Heyland, Dhaliwal, Day, Jain, & Drover, 2004; 
Heyland, Dhaliwal, Drover, Gramlich, & Dodek, 2003; Jolliet et al., 1998; 
McClave et al., 2002; National Collaborating Centre for Acute Care, 2006; 
Stroud, Duncan, & Nightingale, 2003). The recommended acceptable GRVs 
vary widely, from 150mL to 500mL, and management strategies range from 
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ceasing enteral nutrition infusions for an elevated GRV, to continuing with 
caution. Furthermore, the use of GRVs as a marker for tolerance remains 
contentious and is related to the lack of reliability in the measure (Bochicchio 
et al., 2006; Chang et al., 2007; Kompan, Vidmar, Spindler-Vesel, & Pecar, 
2004; Landzinski, Kiser, Fish, Wischmeyer, & MacLaren, 2008; Lin & Van 
Citters, 1997; MacLaren, Kiser, Fish, & Wischmeyer, 2008; McClave et al., 
2005; McClave & Snider, 2002; Metheny, 2008). 
 
Debate in the management of GRVs 
 
It has been suggested that the use of GRVs has never been shown to improve 
patient outcome or reduce complications and thus there is little point in 
standardising this practice (Parrish & McClave, 2008). Poor sensitivity, 
specificity and accuracy in the GRVs correlation to gastric emptying or 
predicting outcomes means these GRVs should not be solely relied upon in 
clinical practice to direct patient care (Parrish & McClave). Despite this, high 
gastric residual volumes have been identified as one of the primary reasons for 
discontinuing enteral nutrition (McClave et al., 1999). 
 
One recent prospective observational study in the United States of America 
(USA) suggested removing the measurement of GRVs from enteral nutrition 
protocols to improve delivery (O'Meara et al., 2008). Metheny (2008) critiqued 
this study, and argued that GRV assessment may identify patients at high risk 
for aspiration and aspiration-related pneumonia. What is apparent is that there 
remains inconsistent evidence regarding the role of assessment of GRVs, in 
conjunction with a clinical assessment of tolerance, in the enterally fed 
critically ill patient. It may still be appropriate to assess GRVs until more data 
is available recommending other measures (Parrish & McClave, 2008).  In 
order to ensure that all possible sources of information pertaining to GRVs 
were identified, on-line databases and websites related to critical care, ICU, 
dietetic societies, organisations, and associations internationally were reviewed 
for current recommendations, guidelines, consensus statements and 
collaborative reports.  
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Professional recommendations and guidelines 
 
Several professional recommendations and guidelines exist to inform practice 
surrounding the management of GRVs in the ICU adult enterally fed patient. 
Literature and systematic reviews were sought through a search of electronic 
databases. The findings the search were examined for consensus or 
disagreement of their principle findings related to specified GRVs, and the 
implications drawn from the primary research reviewed. Principle findings are 
displayed in Table 1. 
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Table 1. Reviews, professional guidelines, and recommendations for GRV 
management in the enterally fed adult patient  
  
Professional Groups GRV and action recommended 
American Gastroenterological 
Association (1994) 
GRV > 200mL: prompt concern about intolerance and 
closely monitor although they suggest that a single high 
GRV is not cause to cease enteral nutrition. 
European Society of Intensive 
Care Medicine (Jolliet et al., 
1998) 
GRV > 300mL: decrease enteral nutrition infusion rate 
by 50% for 4-6hr, then resume over 24-48 hrs while 
monitoring GRV twice daily and administering a 
prokinetic. 
American Society for Parenteral 
and Enteral Nutrition Board of 
Directors & The Clinical 
Guidelines Task Force (2002) 
GRV > 200mL: cease enteral nutrition if this occurs on 
two successive assessments. 
Canadian Critical Care Trials 
Group, (Heyland et al., 2003) 
GRV = 250mL: tolerate and consider administering a 
prokinetic at the initiation of enteral nutrition to 
optimise delivery to the critically ill patient 
British Society of 
Gastroenterology (Stroud et al., 
2003) 
GRV > 200mL: reduce feeding rates. 
National Collaborating Centre 
for Acute Care (2006) 
GRV > 200-300mL: consider as a high aspirate, reduce 
continuous feeding rate and/or introduce prokinetics 
National Institute for Health 
and Clinical Excellence (2006) 
GRV = 200-300mL: consider as „large‟, depending on 
local policy, reduce infusion rate or consider prokinetics. 
Dietitians Association of 
Australia Nutrition Support 
Interest Group (2007) 
GRV > 500mL: consider as „large‟ and to replace up to 
500mL. 
GRV > 200mL: take care to minimise aspiration risk. 
Society of Critical Care 
Medicine and American Society 
for Parenteral and Enteral 
Nutrition (Martindale et al., 
2009) 
GRV < 500mL: avoid holding enteral nutrition in the 
absence of other signs of intolerance 
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Review and critique of guidelines and recommendations 
 
As part of the literature review to provide a rationale for this SR, professional 
recommendations and guidelines were reviewed. There was considerable 
disparity in the recommendations and guidelines of the professional groups and 
the reviews internationally. The lowest recommended GRV to accept was 
150mLs, although this was also the earliest dated review identified in the 
search (Cerra et al., 1997). Since the year 2000, the minimum GRV to accept 
was 200mL, with the highest being 500mL (Dietitians Association of Australia 
Nutrition Support Interest Group, 2007; Martindale et al., 2009; McClave et al., 
2002; McClave & Snider, 2002). However, each of these latter higher 
recommendations relied heavily on the review of McClave and Snider (2002). 
 
There was similar disparity in recommended actions in response to specified 
GRVs. The most common recommended action was to reduce the enteral 
Reviews GRV and action recommended 
Cerra et al. (1997) GRV > 150mL: moderate infusion rate and consider 
total parenteral nutrition or small bowel feeding. 
Edwards & Metheny (2000) GRV ≥ 200mL: prompts concern related to enteral 
nutrition tolerance. 
McClave & Snider (2002) GRV < 400-500mL: unless there is overt regurgitation 
or aspiration, continue delivery of enteral nutrition. 
Also, trend in GRV may be more important than a single 
elevated GRV. 
McClave et al. (2002) GRV < 500mL: enteral nutrition should only be stopped 
if there is overt regurgitation or aspiration. 
GRV < 500mL be returned to the patient. 
GRV = 200-500mL: careful bedside evaluation and risk 
reduction algorithms. 
Bowman et al. (2005) GRV > 250mL: stop feeding. 
Kattelmann et al. (2006) GRV = 250mL: accept this and evaluate the clinical 
situation, but if there are two or more consecutive GRV 
of 250mL stop the delivery of enteral nutrition. 
Bourgault et al. (2007) GRV = 200mL: assess the patient for indications of 
enteral nutrition intolerance. 
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nutrition infusion rates (Cerra et al., 1997; Jolliet et al., 1998; National 
Collaborating Centre for Acute Care, 2006; National Institute for Health & 
Clinical Excellence, 2006; Stroud et al., 2003). Other recommendations 
included to cease the enteral nutrition (American Society for Parenteral and 
Enteral Nutrition Board of Directors & The Clinical Guidelines Task Force, 
2002; Bowman et al., 2005; Kattelmann et al., 2006), to introduce prokinetics 
(Heyland et al., 2003; Jolliet et al., 1998; National Collaborating Centre for 
Acute Care, 2006; National Institute for Health & Clinical Excellence, 2006), 
to monitor the patient closely (American Gastroenterological Association, 
1994; Edwards & Metheny, 2000; McClave & Snider, 2002), or to implement 
aspiration risk reduction methods (Dietitians Association of Australia Nutrition 
Support Interest Group, 2007; Martindale et al., 2009; McClave & Snider, 
2002). Some recommendations included the combination of several of the 
above actions, for example, to introduce prokinetics and implement aspiration 
risk reduction methods. The quality of evidence for the basis of these 
recommendations varied considerably. 
 
Of the 15 recommendations, three were clearly based on a reproducible search 
strategy (Edwards & Metheny, 2000; Heyland et al., 2003; Kattelmann et al., 
2006), five provided clear documentation of identification of the strength of the 
recommendations or a level of evidence (American Society for Parenteral and 
Enteral Nutrition Board of Directors & The Clinical Guidelines Task Force, 
2002; Heyland et al., 2003; Kattelmann et al., 2006; Martindale et al., 2009; 
Stroud et al., 2003), two provided evidence of critical appraisal of the research 
(Heyland et al., 2003; McClave & Snider, 2002), four were clearly peer 
reviewed (American Gastroenterological Association, 1994; Dietitians 
Association of Australia Nutrition Support Interest Group, 2007; Heyland et 
al., 2003; Stroud et al., 2003), and only one appeared to have been validated 
(Heyland et al., 2003). 
 
In summary, there were several existing reviews and clinical practice 
guidelines with recommendations related to GRVs. A variety of GRVs were 
highlighted as the maximum value to potentially consider for enteral nutrition 
intolerance, ranging from 150mL to 500mL. Various interventions were 
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recommended related to the specified GRVs, including cessation of enteral 
nutrition, reducing enteral nutrition, continuing enteral nutrition with careful 
assessment, implementing alternative strategies to reduce the potential risk of 
aspiration, and introducing prokinetics. These recommendations were 
supported from sources ranging from a single expert opinion or a single 
randomised controlled trial, to a systematic review of several research trials, 
which reflects the disparity in the rigour of the evidence-base. 
  
Systematic review objectives 
 
What has been highlighted so far is the potential scope for a systematic review 
to inform this topic more effectively than the existing literature to date. It is 
essential to balance important benefits against important harms when 
administering enteral nutrition and this is demonstrated in the objectives of this 
systematic review. The objectives seek the potential benefits of the delivery of 
optimal caloric intake by identifying the best evidentiary GRV. This is 
balanced against the complications related to accepting a GRV too high or too 
low, potentially predisposing the adult ICU patient to harm. 
 
The aim of this systematic review was to investigate, from the year 1998 to 
2008, GRVs in the gastrically fed adult ICU patient related to the primary 
outcome measures indicative of: accepting a specified GRV too high, and 
hence placing the patient at risk of vomiting, regurgitation, aspiration of gastric 
contents and potentially aspiration pneumonia; or accepting a specified GRV 
too low, and hence not achieving caloric needs, potentially placing the patient 
at risk of malnutrition and increased morbidity. This systematic review sought 
to answer the research question: what is the maximum GRV to accept and 
continue the delivery of enteral nutrition in the ICU adult patient? The key 
research objectives included to: develop an appropriate research method to 
answer the question; conduct the systematic literature search; critically 
appraise the results of the systematic literature search; discuss the results of the 
systematic review of the literature considering the position of key reference 
groups related to this subject; identify limitations of the systematic review; 
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draw on implications for current practice to be disseminated; and finally, 
identify future opportunities for research. 
 
This background chapter contextualised GRVs in relation to nutrition in the 
adult intensive care setting. The implications of tradition, ritual, and evidence 
based practice in nursing were considered in association with optimising the 
delivery of enteral nutrition. This was positioned within the literature that 
identified recommendations related to specified GRVs in the enterally fed adult 
ICU patient. The aim of the systematic review was identified and the 
overarching objectives were outlined. 
  
40 
 
CHAPTER 3 METHODOLOGY 
 
The previous chapter described the background and context to the use of GRVs 
in the delivery of enteral nutrition. Clinical practice guidelines and review 
recommendations were identified and critiqued. The objectives and aims for 
the systematic review were outlined. The methodology will now be addressed 
in more detail. This chapter initially highlights the use of evidence-based 
practice in nursing. There is discussion of the rationale for conducting a 
systematic review and meta-analysis in order to answer the objectives of this 
research project. The format of the systematic review is addressed, specifically 
why the Cochrane Collaboration methodology was used for the systematic 
review, and the structure of the Cochrane systematic review is described. Two 
tools for the assessment of the risk of bias are introduced, and a method of 
assessing the level of quality of evidence is identified. This is followed by 
defining the data extraction process and a discussion related to the promotion 
of reliability and validity. 
 
Evidence-based practice 
 
For the practice of managing GRVs to be evidence based, evaluation of the 
research is required. Using the best possible evidence in the provision of 
patient care is widely supported both in the literature, and in organisations 
which support and promote the development and dissemination of research 
(Fulbrook & Mooney, 2003; Higgins & Green, 2008; Houser, 2008; Joanna 
Briggs Institute, 2008; National Institute for Health & Clinical Excellence, 
2006; Polit & Beck, 2008; Rycroft-Malone et al., 2004). Engaging in evidence-
based nursing practice has become an expectation (Gillis & Jackson, 2002). 
Determining what evidence is, and how to use evidence, is thought to be more 
challenging (Rycroft-Malone et al.). 
 
Research, clinical experience, patient experience, and local information are all 
proposed as sources of evidence supporting a broader definition of evidence-
based patient-centred care (Rycroft-Malone et al., 2004). DiCenso, Cullum, 
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and Ciliska (1998) highlight the impact of the availability of resources to 
achieving evidence-based patient-centred care. A systematic approach both to 
research, and to the evaluation of research, is deemed as essential when 
evaluating the effectiveness of an intervention (Gillis & Jackson, 2002). 
Nursing accountability, related to quality, safety and cost effectiveness, elicits 
the need for streamlining care, with the elimination of unnecessary and 
ineffective practice (Houser, 2008). With this in mind, the most appropriate 
research approach to answer the aims and objectives of this research project 
will now be discussed. 
 
Systematic reviews and meta-analyses 
 
Several possible research methods were considered, prior to electing a 
systematic review and meta-analysis, to answer the research question: what is 
the maximum GRV to accept and continue the delivery of enteral nutrition in 
the ICU adult patient? The search for evidence to answer a research question 
may be successfully conducted using qualitative and quantitative research 
methodologies, either individually or a combination of both (Houser, 2008). 
The most appropriate method to inform a research question has been described 
as the method that identifies the best evidence, using the type of research most 
methodologically appropriate, rigorous, and clinically relevant (Polit & Beck, 
2008). Three potential options considered for this research thesis were a 
narrative literature review, a randomised controlled trial, or a systematic review 
and meta-analysis. To ascertain which of these research methods to elect, the 
literature was consulted in order to identify which would provide the best 
possible evidence to answer the research question. 
 
Stevens (2001) suggests that building the bridge between research and practice 
is challenging. This is due to the disparate nature of research and clinical 
practice, particularly with respect to the way knowledge is shared. Specifically, 
the language used may be a barrier to building the bridge. Scientific knowledge 
based on accuracy and reported in scientific terms may not meet the needs of 
those working in the clinical field. Clinicians may require reporting based on 
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clinical relevance, usefulness and timeliness (Stevens). Randomised controlled 
trials, systematic reviews and meta-analyses are assigned the highest level of 
evidence in clinical research (Melnyk, 2004; Polit & Beck, 2008; Stevens). 
These are followed by observational studies, including cohort and case 
controlled studies (Polit & Beck). Assigning a level of evidence to a particular 
piece of research provides the reader with information related to the quality of 
methodological design and the potential strength of the research findings 
(Melnyk). Due to its prominent position in the hierarchy of evidence, a 
systematic review and meta-analysis is considered in further detail as the 
research methods to use in addressing the research question. 
 
Traditionally, a review of the literature took the form of a narrative which 
synthesised research findings (Polit & Beck, 2008). Narrative reviews provide 
a broad overview of a specified condition, or treatment, combined with the 
experienced authors practical knowledge (Garg, Hackam, & Tonelli, 2008). 
The narrative review provides evidence to support statements. Whether the 
recommendations are based on the author‟s experience, reviewed literature, or 
one particular study over another, is not specifically clarified. Hence it is 
purported that there is a potential for a narrative review author to selectively 
cite reports to support their personal view (Garg et al.). A more rigorous and 
systematic method of reviewing the literature is depicted in the methodology of 
the systematic review. 
 
The focus of the systematic review and meta-analysis is the application of a 
definitive methodology to the identification and analysis of research, and the 
use of statistical data from quantitative studies (Polit & Beck, 2008). Stevens 
(2001) highlights the strengths of the systematic review as its ability to increase 
the power and validity of the relationship between an intervention and an 
outcome. Furthermore, the systematic review limits bias through the use of 
rigorous scientific methods. 
 
Potentially the systematic review provides a basis for clinical decision
 
making, 
future research planning, and the establishment of clinical policy (Cook, 
Mulrow, & Haynes, 1997). Systematic reviews seek to identify, appraise, and 
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summarise studies relevant to a specific question, and to facilitate appropriate 
decision making (Clarke, 2007). Also, the systematic review enables 
accumulation of evidence and learning from many studies, through its 
methodology, to provide new insights to a particular question (Harden, 2006). 
 
To support the development and dissemination of research, and particularly 
systematic reviews, several collaborative organisations have become renowned 
within the healthcare setting. Two of these include the Cochrane Collaboration 
and the Joanna Briggs Institute (JBI). Each of these organisations supports and 
delivers evidence elicited through research. The JBI promotes their unique 
systematic review approach that supports more diverse forms of evidence. 
Within their conceptual model of evidence-based healthcare, JBI promotes 
evidence generation through discourse, clinical experience and all forms of 
research (The Joanna Briggs Institute, 2008). The JBI was established in 1996 
in Australia, with an overarching goal of translating evidence research into 
practice. Their reviews are classified in terms of feasibility, appropriateness, 
meanfulness, and effectiveness. This research is synthesised and rated 
accordingly. Their reviewer‟s manual highlights their close relationship with 
the Cochrane Collaboration (Joanna Briggs Institute, 2008). The JBI purport 
their own position as leaders in systematic reviews that encompass qualitative, 
economic and policy research, and point researchers who conduct systematic 
reviews of effects towards the Cochrane Review Groups (The Joanna Briggs 
Institute, 2008). 
 
Comparatively, the Cochrane Collaboration reviews focus on evidence 
identified in relevant scientific studies (The Cochrane Collaboration, 2008). 
The Cochrane Collaboration was founded in 1993 and seeks to support, 
promote, and disseminate the search for evidence from clinical trials and 
studies of healthcare interventions. Their database of systematic reviews is 
published quarterly. These reviews aim to establish the consistency or variance 
of effects of healthcare. With this in mind, and considering this systematic 
review seeks to evaluate the effect of a healthcare intervention using clinical 
trials rather than discourse or clinical experience, the chosen methodology to 
conduct this review is using the Cochrane Collaboration systematic review 
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framework. This type of systematic review was selected to promote reliability 
and rigour in the research methods, and to enhance the validity of the results 
identified through evidence based on scientific studies. 
 
With the numerous clinical practice guidelines and reviews available with 
recommendations related to GRVs, it was anticipated that there would be a 
large number of scientific studies that would inform the research question of 
this systematic review. Due to this potential, conducting a subsequent meta-
analysis of the identified systematic review results was planned. Clarke (2007) 
defines a meta-analysis as combining the results of similar studies to provide a 
more reliable and significant result. Statistical meta-analysis may enable 
pooling of studies to enhance the effect size (Harden, 2006). The potential 
benefits of a meta-analysis include the provision of information which can be 
merged with clinical judgement and contextualised (Acton, 2001). As a result, 
this may enhance clinical decision making and improve health outcomes 
(Acton). 
 
The systematic review process 
 
Prior to the commencement of the systematic review, the Cochrane 
Collaboration requires the development of a research protocol (Green & 
Higgins, 2008). This protocol mitigates the risk of bias in the review process. A 
research protocol was developed by the researcher and is included in Appendix 
1. 
  
Refining the research question 
 
Cochrane reviews require a clearly defined research question incorporating the 
types of participants, interventions (and comparisons), and outcomes. This 
question may describe: participants by the disease, condition or diagnosis, the 
age-group and the setting; interventions by the type of intervention or 
comparison; and outcomes as a potential benefit and/or harm. Asking a clear 
and focused question, which may be formulated as a set of objectives, defines 
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the eligibility criteria of the systematic review (Bigby & Williams, 2003; 
O'Connor, Green, & Higgins, 2008). 
 
 
Search strategy 
 
The search strategy, although specific and reproducible, needs to be extensive 
enough to ensure all relevant studies are identified (Bigby & Williams, 2003; 
Lefebvre, Manheimer, & Glanville, 2008). Many Cochrane reviews are 
restricted to including randomised trials only (O'Connor et al., 2008). What is 
thought to be most important is considering the type of studies that will provide 
the most reliable data to answer the study objectives (O‟Connor et al.). For 
example, non-randomised trials may be considered if the effect (benefit or 
harm) of an intervention cannot be adequately studied by a randomised trial. It 
is essential for this search strategy to identify the appropriate evidence to 
answer the research question. 
 
The eligibility criteria for the study form the basis of the search strategy. This 
specifies the types of participants, interventions and outcomes eligible, and also 
the types of studies to be included in the systematic review. In order to 
minimise the potential risk of bias associated with the exclusion of relevant 
studies, it is not common to add limiters to a search. One example would be 
limiting the timeframe of the search, unless the intervention was only available 
after a particular date or the timeframe was a requirement in order to answer 
the research question (Lefebvre et al., 2008). The search strategy used for the 
identification of eligible studies is provided in the systematic review protocol 
(see Appendix 1). To enhance rigour and clarity in reporting of the systematic 
review, the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) flow diagram was adopted (Moher, Liberati, Tetzlaff, 
Altman, & and the PRISMA Group, 2009). A data extraction tool, to collect 
relevant information from the identified studies, was developed based on the 
recommendations of Higgins and Deeks (2008). 
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Data extraction 
 
Systematic reviews usually require at least two reviewers, who abstract and 
record data. A data extraction form is developed to assist with this process. It is 
recommended, when extracting data, to carefully consider the amount of data 
recorded to ensure enough information is obtained (Higgins & Deeks, 2008). 
Higgins and Deeks also suggest that forms are useable and information is 
applicable to all aspects of the review question and criteria for inclusion. When 
designing a data extraction form, Higgins and Deeks suggest including study 
identification, sample sizes, eligibility criteria with a checklist related to 
criteria met or not met, and outcome data. Furthermore, the inclusion of 
numbers lost in follow-up, size of effect, and quality criteria have also been 
suggested (Bigby & Williams, 2003). Should there be more than one reviewer, 
any differences in opinion would most commonly be settled by consensus 
(Bigby & Williams). 
 
The Cochrane Collaboration clearly outlines methods to minimise the potential 
bias, both throughout the systematic review and meta-analysis process, and 
also for the assessment of bias within the systematic review when evaluating 
included studies for potential bias. 
 
Risk of bias and quality assessment of included studies 
 
Bias is a form of systematic error that may cause underestimation or 
overestimation of the effect of an intervention (Higgins & Altman, 2008). 
Clarity and transparency in the systematic review process, and specifically the 
method, is fundamental to the systematic review definition. When assessing 
included studies in the research process, there are several key sources of bias: 
sequence generation, allocation concealment, blinding, incomplete outcome 
data, and selective reporting (Higgins & Altman). 
 
Sequence generation reduces the chance of selection bias by a random process 
of allocation of participants to different interventions. This process is 
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strengthened by allocation concealment, which prevents those involved in the 
trial having foreknowledge of the random allocations (Gluud, 2006; Schulz, 
1995). Following enrolment, blinding of all personnel involved in the study, 
including both participants and ancillary study personnel, may ensure that all 
participants are exposed to similar conditions throughout the study period 
(Sackett, 2000; Schulz, Chalmers, & Altman, 2002). This would reduce the 
potential for knowledge of the intervention, rather than the intervention itself, 
altering study outcomes (Higgins & Altman, 2008). Both exclusions and 
attrition may contribute to a potential for bias related to incomplete outcome 
data within a study (Gluud, 2006). This may alter estimates related to the size 
of the effect. Selective reporting of the analyses within a study, particularly the 
likelihood of reporting statistically significant differences rather than non-
significant differences, may also result in bias (Higgins & Altman). 
 
Further potential sources of bias may occur, and some of these are dependent 
on particular study designs. For example, in both systematic reviews and meta-
analyses, there are possible publication biases related to positive findings of 
studies being more likely to be published than negative findings of studies 
(Egger & Smith, 1995; Gluud, 2006). Published trials show an overall greater 
treatment effect than grey (not formally published) literature (Hopewell, 
McDonald, Clarke, & Egger, 2007). The presence of publication bias can be 
assessed by a funnel plot (Bigby & Williams, 2003), which graphically plots 
effect estimates against sample sizes to evaluate meta-analysis validity (Egger 
et al., 1997). However, this is not considered reliable for a meta-analysis based 
on a limited number of small trials (Egger et al., 1997). In identifying studies 
for a review, a combination of hand searching and electronic database 
searching is the most comprehensive method (Hopewell et al.). However, 
Hopewell et al. note that where time and resources are limited, electronic 
searching identifies the majority of published trials.  
 
With the potential for bias within both a systematic review and a meta-analysis, 
minimising risk is important (Cook et al., 1997). In order to identify the risk of 
bias within a study, several critical appraisal tools have been highlighted in the 
literature. 
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Critical appraisal and levels of evidence 
 
Critical appraisal tools 
 
One critical appraisal tool available to facilitate appraisal of the quality of 
studies is the Cochrane Collaboration guide (Higgins & Altman, 2008). This 
tool recommends the assessment of several areas specifically related to: 
allocation; blinding; follow-up and exclusions; selective reporting; and other 
potential sources of bias. This assessment tool outlines the framework for 
assessing the risk of bias (see Appendix 2). A further framework for critical 
appraisal is that of the „Strengthening the Reporting of Observational Studies 
in Epidemiology‟ (STROBE) guide (von Elm et al., 2007), which provides a 
checklist of items that should be addressed in reports of observational studies 
(see Appendix 3). Using these critical appraisal checklists facilitates a 
structured approach to the quality assessment of the studies included in a 
systematic review. 
 
However, Moher et al. (1995) have investigated checklists and scales that assist 
in the assessing and reporting of randomised controlled trials, and found 
several shortcomings in aspects related to the design and conduct of trials. 
Jadad et al. (1996) describe the development of a tool to assess randomised 
controlled trials for quality, and the impact of rater blinding on the quality 
assessment. Within the Jadad et al. study blinded assessments of randomised 
controlled trials were significantly lower and more consistent than open 
assessments. One implication of this is that a blinded approach to appraisal of 
the included studies would enhance consistency and minimise potential bias, 
should this be feasible. 
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Assigning levels of evidence 
 
Following the critical appraisal of a study, it may be possible to assign a level 
of evidence to the research. One example of an approach to the assignation of a 
level of evidence is the „Grades of Recommendation, Assessment, 
Development and Evaluation‟ (GRADE), (see Appendix 4). Assigning a level 
of evidence to a study may facilitate identifying the quality and strength of the 
research methods used (Melnyk, 2004). The Cochrane Collaboration (Reeves, 
Deeks, Higgins, & Wells, 2008) outline the GRADE approach to guide 
appropriation of a level of quality to a body of evidence (see Appendix 4). 
 
Data analysis and synthesis 
 
Either a statistical or narrative structure may be used to analyse the study 
characteristics and findings of a systematic review (Deeks, Higgins, & Altman, 
2008). It is generally recommended that data and analyses within a Cochrane 
review are reported in the form of outcome data, forest plots and meta-analysis 
of the results (Schunemann et al., 2008). Should the data not be sufficiently 
suitable for a meta-analysis, a subjective narrative assessment of the data may 
be made. This assessment would draw from the data extraction, summarising 
study characteristics and data related to specified outcomes in the form of a 
narrative. Within a meta-analysis, it is essential to assess for homogeneity of 
the studies. Homogeneity is defined as the similarity of studies with respect to 
study methods, samples, interventions and levels of quality (Acton, 2001). It is 
likely that there will be some variation between studies, and this is referred to 
as heterogeneity (Acton). Evaluating and ensuring a high level of clinical, 
methodological and statistical homogeneity are fundamental to the validity of a 
meta-analysis (Deeks et al., 2008). 
 
Deeks et al (2008) have outlined criteria to assess sources of potential 
heterogeneity. They suggest assessing for clinical heterogeneity by considering 
the specific interventions and patient characteristics. If the studies are clinically 
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homogenous, methodological heterogeneity may be determined by considering 
the use of blinding, allocation concealment, and outcome measures. Should the 
studies be both clinically and methodologically homogenous, statistical 
heterogeneity may be determined by assessment of outcome measures with 
subgroup or sensitivity analyses using the chi-squared test, which would be 
included in forest plots (Deeks et al.). This test would measure whether 
identified differences in results could be attributable to chance alone. 
Inconsistency may be measured using I-squared (I
2
) to identify whether 
variability in effect may be due to heterogeneity or purely chance (Deeks et 
al.). Should data from randomised controlled trials be of sufficient quality and 
generalisability, these may be combined in a meta-analysis to provide a pooled 
effect estimate. Whether a meta-analysis is possible or not, a systematic, 
consistent, and ordered approach to presenting the data should be adopted. This 
may include comparisons and outcomes specified in the protocol, or 
alternatively a summary of findings table (Schunemann et al., 2008). 
 
This methodology chapter has discussed the rationale for using the systematic 
review with a meta-analysis in the context of evidence-based practice. The 
Cochrane Collaboration systematic review methodology has been presented as 
a way to systematically identify, appraise, and report available evidence in 
order to answer the research questions. The process of conducting a systematic 
review has been outlined, from the formulation of the research question and the 
search strategy, through to the data collection and analysis, and finally to the 
presentation of the results. A discussion of potential sources of bias, and the 
critical appraisal tools available to assess for the risk of bias, have been 
provided. The method chapter will now apply this methodology to the research 
question, in order to develop a process for this systematic review to identify, 
appraise and report the evidence that is available to inform the research 
objectives.  
  
51 
 
CHAPTER 4 METHOD 
 
The methodology chapter has placed the systematic review and a meta-analysis 
within the context of developing evidence-based practice. The Cochrane 
Collaboration methodology of a systematic review with a meta-analysis has 
been described as the framework for this research project. The rigorous 
methodology of the Cochrane Collaboration systematic review was proposed 
as a framework to provide structure, rigour, and clarity to this systematic 
review. This method chapter defines the criteria for considering the studies for 
this review, including the types of studies, participants, interventions, and 
outcome measures eligible for inclusion. The search method is described for 
identification of the studies, and the method of data collection and analysis are 
outlined. Variation from the methods outlined in the protocol is discussed.  
 
This systematic review was conducted in order to investigate gastric residual 
volume management in the gastrically fed adult ICU patient. This related 
specifically to the primary outcome measures indicative of: accepting a 
specified GRV that is too high, and hence placing the patient at risk of 
vomiting, regurgitation, aspiration of gastric contents and potentially aspiration 
pneumonia; or accepting a specified GRV that is too low, and hence not 
achieving caloric needs, potentially placing the patient at risk of malnutrition 
and increased morbidity. 
 
Criteria for considering studies for this review 
 
The criteria for considering studies for this review relate to the types of studies, 
participants, interventions and outcome measures. 
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Types of studies 
 
Four types of studies were eligible for inclusion: randomised controlled trials 
with random or quasi-random allocation of subjects to intervention and control 
groups; case controlled studies; cohort studies; and observational studies. 
 
Types of participants 
 
Included were studies of participants aged 16 years or over, in the critical care 
or intensive care unit, and delivered enteral nutrition by a nasogastric, 
orogastric, or percutaneous endoscopic gastrostomy tube. 
 
Types of interventions 
 
Studies which compared two or more GRVs were included. 
 
Types of outcome measures 
 
Primary outcomes eligible for inclusion were caloric requirements met, and/or 
adverse events including vomiting (or emesis), regurgitation, and/or aspiration.  
 
Search methods for identification of studies 
 
The databases searched included: The Cochrane Library; CINAHL Plus with 
Full Text (EBSCO host via helicon); AMED, Ovid Nursing Full Text plus, 
EMBASE, CDSR, ACP Journal Club, DARE, CCTR, CLCMR, CLTA, 
CLEED, OVID MEDLINE (R) (Ovid SP); Proquest via helicon (advanced 
search); Pubmed via helicon (limits “all adult”, “humans”, “abstract”, “title”); 
and all EBM reviews. The key search terms included: „gastric residual‟, 
„gastric aspirate‟, or „residual volume‟; „enteral nutrition‟, „gastric feeding‟, 
„nutrition‟ or „tube feeding‟; and „intensive care‟, „ICU‟ or „critically ill‟. In 
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alignment with the clinical research question, the search was limited to 
research published within the time period of 1998-2008.  
 
Searching other resources 
 
Parenteral and enteral nutrition association websites including: American 
Society for Parenteral and Enteral Nutrition (ASPEN), Australian Society for 
Parenteral and Enteral Nutrition (AUSPEN), European Society for Parenteral 
and Enteral Nutrition (ESPEN), British Association of Parenteral and Enteral 
Nutrition (BAPEN), Canadian Parenteral and Enteral Nutrition Association, 
and the South African Society for Parenteral and Enteral Nutrition, were also 
searched. Critical care websites searched included the Joint Faculty of 
Intensive Care Medicine (JFICM) and the European Society of Intensive Care 
Medicine (ESICM). The computer search was supplemented by citation and 
author review of the articles selected and search of the grey literature. These 
were searched for further relevant literature. 
 
Data extraction and analysis 
 
Selection of studies 
 
In accordance with the defined inclusion criteria in the protocol (see Appendix 
1), titles and abstracts were reviewed by the author for relevance to the 
inclusion criteria. For any uncertainty related to acceptability of the study, the 
full text of the citation was obtained for further evaluation. Following this title 
and abstract review by the author, all primary studies identified in the title and 
abstract review that would potentially meet the inclusion criteria were obtained 
in full-text or portable document format (PDF). The full-text studies or PDFs 
were then reviewed against the inclusion criteria. Justification for excluding 
studies at this stage was documented. The numerical data from this process was 
entered into the PRISMA flow diagram (Moher et al., 2009). Any doubt related 
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to inclusion of a study was discussed with the researcher‟s principal research 
supervisor. There were no disagreements in study eligibility. 
 
Data extraction 
 
A data extraction form was developed by this author for the review which 
provided a tool to collect data from each of the included studies (see Appendix 
5). The data extracted by the author comprised of: study design; types of 
participants, interventions, and outcome measures; sample size; participant 
demographics; methods; and reported outcomes.  
 
Assessment of methodological quality of included studies 
 
Included studies were assessed by the author for methodological quality using 
the applicable risk of bias assessment tools. The prospective study (McClave et 
al., 2005) and the randomised controlled trial (Pinilla et al., 2001) were 
assessed using the risk of bias assessment tool (see Appendix 2), and the 
observational study (Metheny et al., 2008) was assessed using the risk of bias 
assessment tool for a descriptive observational study (see Appendix 3). A level 
of evidence (GRADE) was evaluated and entered onto the data collection form 
by the author. 
 
Data analysis and synthesis 
 
Sources of potential heterogeneity were assessed according to the criteria 
outlined by Deeks et al. (2008). Firstly, clinical heterogeneity was assessed by 
considering the specific interventions and patient characteristics. No studies 
were clinically homogenous hence a meta-analysis was not conducted. As there 
were fewer than ten studies, publication bias was not assessed. No missing data 
was identified in the three included studies. As the data is not eligible for meta-
analysis, and is too disparate for a summary of findings table, the raw data is 
presented from each included study as a narrative summary. 
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This chapter has provided the search strategy for the identification of studies. 
The process of study selection, related to the criteria for inclusion, has been 
described. The method of data extraction was presented, followed by a 
description of the evaluation of risk of bias for the included studies. The data 
analysis and synthesis related to assessment of heterogeneity and the rationale 
for a narrative summary is provided. The results of the systematic review will 
now be presented. 
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CHAPTER 5 RESULTS 
The previous chapter outlined the method for this systematic review, clarifying 
variations from the methodology of a Cochrane systematic review or protocol. 
This chapter presents the results of the systematic review. The search terms and 
numbers of studies retrieved are presented. This is followed by a description of 
the studies, including the characteristics of both the included and excluded 
studies. The included studies are then reviewed with respect to study 
methodologies, participants and settings. Risk of bias is analysed using relevant 
bias risk analysis tools. The effects of comparative GRVs from the studies is 
described, particularly addressing outcome measures, which included caloric 
requirements met and the adverse events (vomiting or emesis, regurgitation, 
and aspiration). 
 
Results of the search 
 
Included studies 
 
The total number of search result hits was 1446 (see Appendix 6). Of these, the 
title and abstract review identified 18 studies as requiring full text review. Of 
these 18 studies, four were clinical trials, seven were case-controlled studies, 
and seven were cohort studies. Three of these studies were eligible for 
inclusion in this review; one prospective study (McClave et al., 2005), one 
prospective observational study (Metheny et al., 2008), and one randomised 
controlled trial (Pinilla et al., 2005). Of these three studies, one sought to 
validate the use of an elevated GRV as a marker for risk of aspiration and 
consequently regulation of the delivery of enteral tube feeding (McClave et al., 
2005). The second study compared gastrointestinal tolerance using two 
different enteral feeding protocols in critically ill patients (Pinilla et al., 2001). 
The third study described the association between GRV and aspiration of 
gastric contents in a group of critically ill patients receiving gastric tube 
feedings (Metheny et al., 2008). The numerical data from this process of 
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inclusion and exclusion is illustrated in the PRISMA flow diagram shown in 
Figure 1. 
 
 
Figure 1. Prisma flow diagram (adapted from Moher et al., 2009)  
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The characteristics of the three included studies (McClave et al., 2005; 
Metheny et al., 2008; Pinilla et al., 2001) are summarised and shown in Table 
2. 
 
Table 2. Characteristics of included studies 
 
Study Methods Participants Intervention Outcome measures 
McClave 
et al. 
(2005) 
 
Prospective 
study 
n = 40 
Demographics: 
mean age 45yrs, 
70% men.  
No sample size 
calculations 
reported. 
Comparison of two 
groups: 
1. Study group:  
GRV > 400mL. 
2. Control group:  
GRV > 200mL. 
1. Caloric goals met. 
2. Regurgitation or 
aspiration. 
3. Development of 
new suspected or 
definitive 
pneumonia. 
Pinilla et 
al. (2001) 
 
Randomised 
controlled 
trial 
n = 80 
Demographics: 
mean age 53 yrs, 
55% men. 
The sample size 
was calculated 
using a power of 
80%. 
Comparison of two 
groups: 
1. Group 1:  
GRV 150mL 
with an optional 
prokinetic. 
2. Group 2:  
GRV 250mL 
with a mandatory 
prokinetic. 
1. High GRV 
(≥150mL). 
2. Emesis. 
3. Days of diarrhoea. 
4. Total intolerance 
episodes. 
5. Time to reach goal 
rate. 
6. Nutritional 
requirement met. 
7. Reasons enteral 
nutrition stopped 
or reduced. 
Metheny 
et al. 
(2008) 
 
Prospective 
observational 
study 
n = 206  
Demographics: 
mean age 52 yrs, 
61% men. 
No sample size 
calculations 
reported. 
Non-interventional. 1. Pepsin assay to 
assess for 
aspiration. 
2. Frequency of high 
GRVs. 
3. Frequency of 
vomiting. 
 
Excluded studies 
 
Fifteen studies did not meet inclusion criteria and were excluded. These studies 
were a combination of both interventional and non-interventional studies. 
Exclusion of these studies was due to lack of separate analysis of the impact of 
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variable GRVs. An indepth description of the characteristics of the excluded 
studies was conducted (see Appendix 7), and the reasons for exclusion are 
shown in Table 3. 
 
Table 3. Excluded studies 
 
 
  
Study Reason for exclusion 
Bochicchio et al. (2006) No analysis of a comparison of two or more GRVs 
Davies et al. (2002) No analysis of a comparison of two or more GRVs 
Desachy et al. (2008) No analysis of a comparison of two or more GRVs 
Elpern, Stutz, Peterson, 
Gurka, & Skipper (2004) 
No analysis of a comparison of two or more GRVs 
Esparza, Boivin, 
Hartshorne, & Levy 
(2001) 
No analysis of a comparison of two or more GRVs 
Fiaccadori et al. (2004) No analysis of a comparison of two or more GRVs 
Kearns et al. (2000) No analysis of a comparison of two or more GRVs 
Kompan et al. (2004) No analysis of a comparison of two or more GRVs 
Kortbeek, Haigh, & 
Doig (1999) 
No analysis of a comparison of two or more GRVs 
McClave et al. (1999) No analysis of a comparison of two or more GRVs 
Mentec et al. (2001) No analysis of a comparison of two or more GRVs 
Montejo (1999) No analysis of a comparison of two or more GRVs 
Montejo et al. (2002) No analysis of a comparison of two or more GRVs 
Neumann & DeLegge 
(2002) 
No analysis of a comparison of two or more GRVs 
Taylor, Fettes, Jewkes, 
& Nelson (1999) 
No analysis of a comparison of two or more GRVs 
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Description of included studies 
 
Participants and setting 
 
Two of the studies were set in the USA (McClave et al., 2005; Metheny et al., 
2008) and one in Canada (Pinilla et al., 2001). The total number of participants 
across all three studies was 326. Sample sizes varied from 40 participants 
(McClave et al.) to 206 participants (Metheny et al.). Mean age across the three 
studies was 48 years (range 18-88 years). The participants of McClave et al‟s 
study had the highest mean age of all groups (54.4 years, range 18-72 years). 
Mean percentage of men across the three studies was higher than women 
(62%). Admitting diagnoses of participants varied between studies. The 
predominant diagnoses in each study were: medical (Pinilla et al); trauma and 
surgery, with a large proportion of participants having head injuries and cranial 
neurosurgical conditions (Metheny et al); and trauma, with a large proportion 
of participants having a closed head injury (McClave et al). 
 
Intubation of participants was a requirement for inclusion in both McClave et 
al.‟s (2005) and Metheny et al.‟s (2008) studies, but was not specified for 
Pinilla et al.‟s (2001) study. Pinilla et al.‟s participants were ≥ 16 years of age, 
whereas McClave et al.‟s and Metheny et al.‟s participants were ≥ 18 years of 
age. McClave et al.‟s participants had a mean acute physiology and chronic 
health evaluation (APACHE) III score of 41, and Metheny et al‟s participants 
had a mean APACHE score of 23. Pinilla et al‟s participants had a mean 
multiple organ dysfunction syndrome (MODS) score of 8, a simplified acute 
physiology score (SAPS) II of 42-44, and a mean trauma injury severity score 
(TISS) of 41. Pinilla et al.‟s participants only received gastric enteral nutrition 
via a nasogastric or orogastric tube, whereas Metheny et al. and McClave et al. 
included participants receiving either nasogastric or percutaneous endoscopic 
gastrostomy tube delivered enteral nutrition. 
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Comparisons of interventions 
 
McClave et al.‟s (2005) study compared a GRV > 400mL, which involved 
enteral nutrition being withheld until the GRV was < 400mL, with a GRV > 
200mL which involved enteral nutrition being withheld until the GRV was < 
200mL. Pinilla et al.‟s (2001) compared a GRV of 150mL and an optional 
prokinetic, with a GRV of 250mL and a mandatory prokinetic. Metheny et al‟s 
(2008) study was non-interventional, but compared three overlapping groups, a 
GRV of at least 150mL, a GRV of at least 200mL, and a GRV of at least 
250mL. 
 
Outcome measures 
 
McClave et al.‟s (2005) outcome measures included the participant‟s caloric 
intake divided by goal calories, the presence of yellow microscopic 
colorimetric microspheres and/or blue food colouring in the patient‟s 
oropharynx (deemed by the authors as reflecting regurgitation) or trachea 
(deemed by the authors as reflecting aspiration), and the development of newly 
suspected or definitive pneumonia. Pinilla et al.‟s (2001) outcome measures 
included high GRV, emesis, days of diarrhoea, total intolerance episodes 
(intolerance was defined by these authors as emesis, high GRV, or diarrhoea), 
time to reach goal rate, percentage of nutritional requirements received by 
patients, and other reasons enteral nutrition was decreased or interrupted. 
Metheny et al‟s (2008) outcome measures were a pepsin assay to assess for 
aspiration, the frequency of high GRVs, and the frequency of vomiting. These 
are depicted in the characteristics of included studies (see Table 2). 
 
Risk of bias in included studies 
 
The methodological quality of the prospective study, the randomised controlled 
trial, and the prospective observational study was assessed by two different 
bias risk analysis tools, appropriate for their differing study methodologies. 
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Analysis of the prospective study and the randomised 
controlled trial 
 
Both the prospective study and the randomised controlled trial were analysed 
for their potential risk of bias using Cochrane‟s handbook for systematic 
review of interventions (Higgins & Altman, 2008), (see Appendix 8). In 
McClave et al.‟s (2005) study, the adequacy of sequence generation and 
allocation concealment was unclear due to the process of randomisation not 
being described. There was no blinding in the study, no incomplete data 
identified, no indication of selective reporting, nor any other potential risks of 
bias identified. The overall level of quality using the GRADE approach 
(Reeves et al., 2008) was identified, by the systematic review author, as 
moderate. 
 
Pinilla et al.‟s (2001) study clearly described adequate sequence generation and 
allocation concealment, however there was no blinding of groups. No 
incomplete data was identified, nor any indication of selective reporting, or any 
other potential risks of bias identified. The overall level of quality using the 
GRADE approach (Reeves et al., 2008) was identified, by the systematic 
review author, as moderate. 
 
Analysis of the prospective observational study 
 
Metheny et al.‟s (2008) study was analysed for the potential risk of bias using 
the STROBE guideline (von Elm et al., 2007), (see Appendix 9). Metheny et 
al.‟s  study identified a clear design with an informative and balanced abstract. 
The scientific background and rationale for their study was presented clearly 
and objectives specified. The key elements of their study design were presented 
early alongside the setting, location, and data collection. Outcome measures 
were identified, including a description of the methods of measurement. 
Potential sources of bias were considered, although there was no discussion as 
to the calculation of the study size. Statistical methods were described, and 
outcome measures were discussed. The key results were summarised and 
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limitations of the study were considered. However, there was no discussion of 
generalisability of the results of the study by the authors. The overall level of 
quality using the GRADE approach (Reeves et al., 2008) was identified, by the 
systematic review author, as low. 
 
Effects of comparisons of interventions 
 
Caloric requirements 
 
Percentage of goal calories infused 
 
The percentage of calories met in McClave et al.‟s (2005) study and Pinilla et 
al.‟s (2001) study are provided in Table 4. McClave et al. found no significant 
difference in the percentage of calories infused between the two groups, 
however they identified that only 5% (n = 1118) of GRV were > 200mL so it 
was possible that the small difference in calories may have been attributable to 
the small difference in GRV. The control group‟s (200mL GRV) percentage of 
calories infused was 77% ± 21%, and the study group‟s (400mL GRV) 
percentage of calories infused was 78% ± 33%. This difference was not 
significant (p = 0.927). 
 
Table 4. Caloric requirements met 
Author GRV 
 150mL 200mL 250mL 400mL 
(McClave et 
al., 2005) 
 77% ± 21%  78% ± 33% 
(Pinilla et al., 
2001) 
70% ± 25%    76% ± 18%  
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Percentage of nutritional requirements received 
 
Pinilla et al. (2001) found a significant difference between groups in the 
percentage of nutritional requirements received, however the use of 
metoclopramide and other antibiotics was significantly different between 
groups, so it was possible that the difference in nutritional requirements 
received may have been attributable to these variables. Group 1‟s (GRV 
150mL, optional prokinetic) percentage of nutritional requirements received 
was 70% ± 25%, and Group 2‟s (GRV 250mL, mandatory prokinetic) 
percentage of nutritional requirements received was 76% ± 18%, p < 0.02. 
 
Adverse Events 
 
Vomiting or emesis 
 
In Metheny et al.‟s (2008) study, 7% (n = 206) of all patients vomited during 
the 3-day study period. The percentage of patients who vomited was not 
discussed in relation to GRV or aspiration. Pinilla et al. (2001) analysed emesis 
by both by the number of patients and by the number of events. Pinilla et al.  
found no significant difference between both groups for either number of 
events or number of patients. Analysis of vomiting by the number of patients 
found that: Group 1 (GRV 150mL, optional prokinetic) = 2/36 patients 
vomited, and Group 2 (GRV 250mL, mandatory prokinetic) = 3/44 (NS) 
patients vomited. Analysis of vomiting by the number of events found that: 
Group 1 (GRV 150mL, optional prokinetic) = 2 events of vomiting occurred, 
and Group 2 (GRV 250mL, mandatory prokinetic) = 4 (NS) events of vomiting 
occurred. 
 
Regurgitation 
 
McClave et al. (2005) identified that the percentage of positive regurgitation 
between groups was not significant, the control group (200mL GRV) was 35% 
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± 27% and the study group (400mL GRV) was 28% ± 25%, p = 0.396. 
However a Tukey test (which compares means from a factor in which all levels 
have equal n in post-hoc analysis, Heiman, 1992), demonstrated there was a 
significant difference in the percent positive regurgitation between PEG and 
NG 12-Fr tubes (p = 0.046). 
 
Frequency of aspiration 
 
Metheny et al.‟s (2008) study assayed a total of 3203 tracheal secretions for the 
presence of pepsin. The mean percentage of tracheal secretions positive for 
pepsin was 36% ± 25%. Of the 206 patients, 93% had at least one tracheal 
secretion positive for pepsin. Metheny et al. then categorised the patients 
according to the frequency of aspiration. They categorised infrequent aspirators 
(n = 117) as patients whose secretions were positive for pepsin in fewer than 
40% of observations (median percentage of pepsin-positive tracheal secretions 
was 19%). Frequent aspirators (n = 89) were defined as patients whose 
secretions were positive for pepsin in 40% or more observations (median 
percentage of pepsin-positive tracheal secretions was 54%). 
 
Metheny et al. (2008) then identified what they considered to be high GRVs. A 
total of 3286 GRVs were measured. The mean of these GRVs was 37mL ± 
37mL. High GRVs were categorised into three groups including: at least 
150mL, and 73% (n = 81) of these were in large-bore tubes; at least 200mL, 
and 75% (n = not provided) of these were in large-bore tubes; and at least 
250mL, and 80% (n = not provided) of these were in large-bore tubes. The 
remainder of the high GRVs were in patients with small-bore tubes. Metheny 
et al. found that 69/81 patients with one or more GRV of at least 150mL had 
been enrolled in the study within 24 hours of the start of feeding (P = 0.008). 
Metheny et al. assessed the relationship between aspiration and GRV and 
found that: the percentage of secretions indicating aspiration that occurred 
when GRVs were between 0 and 50mL was 34% (n = 3286 aspirates); and the 
percentage of aspiration increased as GRVs increased (F = 7.7, P < 0.001, 
where F = frequency). 
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McClave et al. (2005) also identified a percentage of positive aspiration; 
however this was not significant between groups. The control group (200mL 
GRV) was 22% ± 26%, and the study group (400mL GRV) was 23% ± 25%, p 
= 0.903. McClave et al. evaluated regurgitation and aspiration events related to 
an aspiration risk score. The authors based this aspiration risk score on 
previous studies in the literature to evaluate the risk for aspiration. McClave et 
al. found no correlation of aspiration risk score with either regurgitation events 
(p = 0.320), or aspiration (p = 0.910). 
 
Total intolerance episodes 
 
Pinilla et al. (2001) evaluated the total number of intolerance episodes, both by 
patient and by events, and there was no significant difference between groups 
of intolerance episodes by either patient or events. Pinilla et al. found that 
when intolerance episodes were evaluated by patient, Group 1 (GRV 150mL, 
optional prokinetic) = 21, and Group 2 (GRV 250mL, mandatory prokinetic) = 
20 (NS). When intolerance episodes were evaluated by events, Group 1 (GRV 
150mL, optional prokinetic) = 49, and Group 2 (GRV 250mL, mandatory 
prokinetic) = 38 (NS). 
 
Meta-analysis feasibility for comparisons 
 
This systematic review intended to include a meta-analysis of the identified 
results. There was a large void in primary research specifically answering the 
identified question. None of the three included studies were clinically 
homogenous; hence a meta-analysis was not feasible. As there were just three 
included studies, the possibility of publication bias assessment with funnel 
plots was also eliminated.  
 
The results chapter provided a description of the characteristics of the included 
studies. This particularly focused on the participants and setting, the 
interventions and comparisons, and outcome measures. Excluded studies were 
identified and the reasons for exclusion were provided. The three included 
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studies were analysed for their risk of bias. McClave et al. (2005) and Pinilla et 
al. (2001) were analysed using the framework of Higgins and Altman (2008), 
and Metheny et al. (2008) was analysed using the STROBE statement as a 
guide (von Elm et al., 2007). Each of the systematic reviews outcome 
measures, including caloric requirements met, and the potential adverse events, 
were addressed when identifying the effects of the interventions, which 
compared GRVs, in each of the studies. These will be considered further in the 
discussion. 
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CHAPTER 6 DISCUSSION 
 
The previous chapter presented the results of the systematic review. The main 
findings were the identification of three studies related to the systematic review 
objectives, which met the inclusion criteria. The ensuing discussion addresses 
the main results of this systematic review in light of the identified outcome 
measures and related literature. The quality of evidence and the potential for 
bias within the systematic review is discussed. This is followed by a 
concluding statement related to the overall implications of the results for both 
nursing practice and future GRV research. 
 
Summary of main results 
 
The three studies included in the systematic review were McClave et al. 
(2005), Pinilla et al. (2001), and Metheny et al. (2008). Each of these studies 
contained methodological risks of bias and limitations related to their unique 
designs. The three studies included a prospective study (McClave et al.), a 
prospective descriptive study (Metheny et al.), and a randomised controlled 
trial (Pinilla et al.). The comparisons and the primary outcome measures of the 
systematic review are discussed individually. 
 
Comparisons 
 
Two of the studies compared two different GRVs. McClave et al. (2005) 
compared the GRV of 200mL to the GRV of 400mL, and Pinilla et al. (2001) 
compared the GRV of 150mL to the GRV of 250mL. Metheny et al.‟s (2008) 
post hoc analysis compared three overlapping groups; a GRV of at least 
150mL, a GRV of at least 200mL, and a GRV of at least 250mL. 
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Outcomes 
 
The outcome measures included caloric requirements met and adverse events. 
Adverse events included vomiting (or emesis), regurgitation, aspiration, and 
total intolerance episodes. These will now be discussed individually. 
 
Caloric requirements 
 
Accepting a higher GRV contributed to more calories received in one study 
(Pinilla et al., 2001) and no significant difference in calories received in 
another study (McClave et al., 2005). Pinilla et al. compared a GRV of 150mL 
to 250mL, found a significant difference between groups in calories received, 
with the patients randomised to a higher accepted GRV group of 250mL 
receiving more calories. However, the variable of an optional prokinetic in the 
GRV 150mL group versus a mandatory prokinetic in the GRV 250mL group 
may have confounded these results. Despite more calories being received by 
patients when a higher GRV was accepted (Pinilla et al.), the methodological 
limitations to the study related to prokinetic use, reduce the potential 
significance and implications for clinical practice related to finding. McClave 
et al. compared a GRV of 200mL to 400mL, and found no significant 
difference in the calories infused between groups. Of the GRVs, 5% were > 
200mL hence, the lack of a significant difference in calories between groups 
may have been attributable to the small difference in GRVs measured. 
 
Adverse events 
 
Vomiting or emesis 
 
Accepting a higher GRV did not significantly impact on the occurrences of 
vomiting in one study (Pinilla et al., 2001). Pinilla et al.‟s study found no 
significant difference between the 150mL GRV group or the 250mL GRV 
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group, both for the number of occurrences of vomiting and the number of 
patients who vomited (6% & 7% respectively). Metheny et al.‟s (2008) study, 
which evaluated vomiting among participants, found that 7% of all 206 patients 
vomited during the study period, however this was not discussed in relation to 
GRV. The potential implications for practice, related to there being no 
significant difference in the occurrence of vomiting when a higher GRV was 
accepted (Pinilla et al.), are limited by the variation in the use of prokinetics 
between groups. 
 
Regurgitation 
 
Accepting a higher GRV was not associated with a difference in the percentage 
of regurgitation in one study (McClave et al., 2005). McClave et al.‟s study 
found no significant difference in the percentage of positive regurgitation 
between the two groups (200mL GRV compared to 400mL GRV). However, 
their study did not clearly define group characteristics, with respect to PEG and 
NG tube, and with respect to group sample sizes. Thus, although their post hoc 
analysis identified a significant difference between the percentage of positive 
regurgitation between PEG and 12-Fr NG tubes, the impact of this was unclear 
with respect to either the 200mL GRV or the 400mL GRV groups. Thus, 
although their study found no significant difference in the percentage of 
positive regurgitation when accepting a higher GRV, the potential implications 
for clinical practice are limited by these confounding variables. 
 
Frequency of aspiration 
 
Accepting a higher GRV was associated with an increase in the percentage of 
aspiration in one study (Metheny et al., 2008), and was not associated with any 
difference in the percentage of aspiration in another study (McClave et al, 
2005). Metheny et al.‟s study found that 93% of the 206 participants had at 
least one tracheal secretion positive for pepsin. The authors deemed this a 
proxy for the aspiration of gastric contents. They then categorised participants 
according to the frequency of aspiration and assessed the relationship between 
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GRV and aspiration. The result indicated that the percentage of aspiration 
increased as GRVs increased. Although one potential implication for clinical 
practice from this result may point to a higher risk of aspiration for higher 
GRVs, this study found that even participants in the GRV group between 0-
50mL had 34% positive pepsin assays (Metheny et al.). This result may 
demonstrate the high sensitivity of the pepsin test rather than the potential for 
an increased risk of complications with higher GRVs. McClave et al. also 
identified a percentage of positive aspiration, however this was not statistically 
significant between groups. 
 
Total intolerance episodes 
 
Accepting a higher GRV did not alter the occurrence of intolerance episodes in 
one study (Pinilla et al., 2001). Pinilla et al.‟s study evaluated the total number 
of intolerance episodes both by participants experiencing intolerance and by 
the number of total events, between the group where the acceptable GRV was 
150mL and the group where the acceptable GRV was 250mL. This study found 
no significant difference between groups for either evaluation. The potential 
implications related to there being no significant difference in intolerance 
episodes when accepting the higher GRV is limited due to the variation in 
prokinetic use between groups within the study.  
 
Overall completeness and applicability of evidence 
 
Of critical relevance to this thesis, no one study, or a combination of studies, 
provided conclusive evidence to support the use of one particular GRV over 
another. It is essential to balance important benefits against important harms 
related to the use of one GRV over another, and this was one of the objectives 
of this systematic review. This would enable the delivery of optimal caloric 
intake by identifying the best evidentiary GRV, which would be balanced 
against the complications related to accepting a GRV either too high or too 
low. Of the three included studies, each contributed evidence towards one or 
more of the objectives of the review question. The quality of these studies, and 
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the contribution of their evidence to the objectives of the review question, is 
discussed in the ensuing evaluation of the quality of the evidence. However, 
there was not sufficient evidence in any one study to address all of the 
objectives of the review. In the context of current practice, the results of this 
review may reflect the ongoing inconsistencies in the management of GRVs, as 
previously highlighted in the background chapter. 
 
Quality of the evidence 
 
The methodological quality of nutritional support trials in the critically ill 
patient population has been described as poor (Doig, Simpson, & Delaney, 
2005). Doig et al. identified and assessed 111 articles, regarded as primary 
nutritional support studies
 
reporting clinically meaningful outcomes. They 
measured three domains related to quality: randomisation, blinding, and 
presence of data, and found the methodological quality of the nutritional 
support trials were significantly worse in all three domains when compared to 
the sepsis trials. What their study highlighted is closely associated with the 
findings in this systematic review. The questionable methodological quality of 
the studies identified in this systematic review limit the ability to formulate 
strong conclusions based on the results. A further potential methodological 
limitation to nutritional support studies, highlighted by Kreymann et al. (2006), 
is the varied use of the heterogeneous terms „ICU patients‟ and „critically ill 
patients‟. As a result, where possible in this systematic review, disease severity 
scores (APACHE, TISS) have been highlighted in patient characteristics to 
facilitate identification of homogeneity of population groups. 
 
Internal validity 
 
Each study included in the systematic review is now assessed with respect to 
its internal validity. The body of evidence identified in this systematic review 
does not allow a robust conclusion to be made regarding the objectives of this 
review. Three studies were included in the systematic review; one prospective 
study, one prospective descriptive study, and one randomised controlled trial. 
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Each study had methodological limitations which increased their risk of bias, 
and the lack of homogeneity between studies removed the possibility of 
comparison. 
 
McClave et al. (2005) 
 
McClave et al.‟s (2005) study was dependent on physician and primary care 
team decision making in the enteral nutrition management. During their study, 
the decision to stop enteral nutrition was based on concern for aspiration. This 
decision may have been as a result of observed vomiting/regurgitation, 
increasing abdominal discomfort, findings of increased abdominal distension, 
or the development of hypoactive-to-absent bowel sounds on physical 
examination. The decision was discretional to attending physicians and the 
primary care team. This dependence on subjective decision making processes 
of clinicians, rather than a standardised process, reduced the internal validity of 
the study. 
 
The potential for discord in physicians practice, regarding the management of 
enteral nutrition, has been highlighted in other research, for example Behara et 
al. (2008). Behara et al. conducted a survey of attending physician‟s ratings 
related to their weighting of the importance of nutrition, their comfort level 
with nutrition support, and their understanding of nutrition support in critically 
ill patients. They found considerable differences in both perception and 
practice of individual physicians related to initiation and management of 
nutrition in the ICU patient population. 
 
A further limitation to McClave et al.‟s (2005) study was the lack of blinding 
within the study. Although it may not have been possible or appropriate for 
McClave et al.‟s study, there remains the possibility of bias as there was still 
the potential for MDT members to treat groups differently. Chalmers et al. 
(1981) suggest ideally quadruple blinding (randomisation, physicians, patients, 
ongoing results) to enhance randomised controlled trial quality. Furthermore, it 
is possible that the applicability of the study may be compromised due to the 
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large percentage of the participants in McClave et al.‟s study having a closed 
head injury. This group of patients have been previously studied and identified 
as having a high probability of feeding intolerance (e.g., Bochicchio et al., 
2006). This prospective study of 57 consecutively admitted severely traumatic 
brain-injured patients primarily demonstrated that severely traumatic brain-
injured patients in an induced barbiturate coma have significantly poor 
tolerance of enteral nutrition. 
 
A further limitation in McClave et al.‟s (2005) study was related to the 
differing tube feeding properties, such as PEG or NGT, or small bore versus 
large bore. The variability in GRVs aspirated from small bore compared to 
large bore NG tubes has been identified in previous research (Metheny et al., 
2005). Also, McClave et al.‟s participants were more likely to receive an early 
tracheostomy, which may have required the use of neuromuscular blockade. 
The use of a neuromuscular blockade may influence the participants ability to 
tolerate enteral nutrition (Tamion et al., 2003). In McClave et al.‟s study, the 
percentage of positive regurgitation difference between PEG vs NGT was 
statistically significant, with the percentage of regurgitation in those 
participants with a NGT being greater. However the number of patients 
percutaneously fed with positive regurgitation, compared with those 
nasogastrically fed in each group, was not clearly defined. The lack of clarity 
in group characteristics limits the interpretation of the results related to GRVs 
and their relationship to aspiration. It would have been beneficial for McClave 
et al.‟s study to have reported the number and tube type in each group to 
ascertain if this possible difference would have impacted on the results. More 
information related to the aspiration risk and bowel function scores, of which 
allocation was weighted arbitrarily, would have reduced questions related to 
both the interpretation and validity of McClave et al.‟s results. 
 
The tube feeding initiation process, which is described by McClave et al. 
(2005) as either rapid start-up or stepwise progression (start 25mL/hr, increase 
by 25mL/hr every eight hours until goal rate) was not adequately described or 
analysed, particularly between group differences related to the process of rapid 
or stepwise initiation. The addition of this information would have confirmed if 
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groups were treated differently. A disadvantage of the assessment of quality 
processes in reports of studies is that the assessment is largely dependent on the 
information made available in reports. Jadad et al. (1996) highlighted that in a 
quality assessment, despite a trial being methodologically sound, it may be 
deficient due to space constraints in printed journals. The impact of this may 
result in the authors referring to previous publications for details of trial 
methods. This aspect was apparent in McClave et al.‟s study, where they 
referred to a description and the validation of the aspiration risk and bowel 
function scores within previous research, but did not detail this in their report. 
 
Another point to consider regarding McClave et al.‟s (2005) study was that 
their small, apparently uncalculated, sample size resulted in several GRVs 
being collected on the same patients. Had this been attended to in the method, 
whereby each participant would have had the same number of GRV collected 
both within and between groups, these results could have been used in the 
analysis. However, this was not sufficiently clarified, and thus it remains 
unclear if the use of several GRVs being collected on the same patients may 
have skewed the results. In aiding the replicability of their study, a discussion 
of exactly how, and by whom, the GRVs were measured would have been 
beneficial. It is likely that different members of the MDT and different 
clinicians may conduct the aspiration of gastric contents procedure differently. 
 
To summarise, McClave et al.‟s (2005) study highlighted that changing the 
acceptable GRV from 200mL to 400mL made no difference in the frequency of 
aspiration. However, because of uncertainties related to sample size and 
characteristics (i.e., the large proportion of head injured patients and the 
proportion of PEG delivered enteral nutrition in each group), and the potential 
impact of early tracheostomy (and possible neuromuscular blockade), it would 
not be possible to change current practice related to these findings alone. 
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Pinilla et al. (2001) 
 
Pinilla et al.‟s (2001) study also contained methodological uncertainties. Pinilla 
et al. used a mandatory prokinetic in one group, and an optional prokinetic in 
the other. The different use of a prokinetic may have confounded these results 
related to: GRVs, nutritional requirements received, and total number of 
intolerance episodes. Reasons for cessation or reduction of feedings extracted 
from ICU flow sheets, progress notes, physicians‟ orders, and radiology 
reports, means that there is a reliance on staff completing the documentation. 
Recent research has identified that documentation from these sources may be 
both inadequate and variable (Saranto & Kinnunen, 2009). Similar to McClave 
et al.‟s (2005) study, there was no blinding within the study. Blinding of 
subjects is unlikely to have been possible due to nurses and clinicians being 
required to carry out the GRV assessment and management. Although blinding 
is not always possible, there is a potential bias effect; for example, the clinician 
reviewing the GRV being more vigilant in one particular group compared to 
another. 
 
Although Pinilla et al. (2001) found patients had improved tolerance to enteral 
nutrition where a mandatory prokinetic and a higher GRV of 250mL was used 
(compared with 150mL and an optional prokinetic), several factors, outlined 
below, impact on using this information to inform the systematic review 
question. They sought to compare gastrointestinal tolerance of two enteral 
feeding protocols in critically ill patients, however added two variables – a 
change in accepted GRV and also a mandatory versus an optional prokinetic. It 
is unclear if the statistical analysis enabled adequate comparison of the two 
groups, minimising the potential for the two variables to confound the study‟s 
results. Also, similar to McClave et al.‟s (2005) study, there was a reliance on 
staff documenting the reasons for cessation of enteral nutrition. 
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Metheny et al. (2008) 
 
Metheny et al.‟s (2008) study differed significantly from both McClave et al.‟s 
(2005) and Pinilla et al.‟s (2001) studies primarily in the methodology. 
Metheny et al.‟s descriptive study‟s results identified that the percentage of 
aspiration increased as GRVs increased. For example, aspiration was higher in 
the „GRV at least 250mL group‟ than the „GRV 0-50mL group‟, which implies 
that in accepting a GRV of at least 250mL, puts patients at greater risk of 
aspiration. However, the authors discuss the lack of randomisation, or control 
for tube types or other treatment conditions, which potentially introduces bias 
into their study. Like McClave et al.‟s study, the lack of clarity around tube 
types in their groups presents a potential confounding variable related to the 
implications from the results associated with risk of aspiration. No discussion 
of the feeding regimen or the volumes infused is provided, making study 
replication difficult. 
 
One consideration regarding Metheny et al.‟s study is that even when the GRV 
was 0-50mL, participants still had positive pepsin assays of their tracheal 
secretions, so regardless of accepted GRV, patients are still potentially at risk 
of aspiration. This result is based on the assumption that the assay is a proxy to 
aspiration of gastric contents. The pepsin assay is deemed to be highly 
sensitive and specific (100% and 92% respectively) related to pepsin detection 
in the proximal oesophagus and has previously been validated (Potluri et al., 
2003). Metheny et al.‟s results suggested there is an increased risk of aspiration 
associated with higher GRVs, however the identified inconsistencies in this 
relationship, the frequency of aspiration to occur even in the „GRV 0-50mL 
group‟, and the associated potential for bias related to study methodology 
reduces the ability for implications to be drawn for this systematic review 
question. That is, no acceptable GRV was identifiable from this study.  
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Contributions from excluded studies 
 
Despite being excluded from the systematic review due to there being no 
separate analysis of the impact of variable GRVs, several of the excluded 
studies do provide insight into an informed discussion related to the 
identification of a specified acceptable GRV (Davies et al., 2002; Desachy et 
al., 2008; Kompan et al., 2004; Mentec et al., 2001; Montejo et al., 2002). 
Potential acceptable GRVs which were identified as causing few or rare 
complications for patients included 250mL (Davies et al.), 300mL (Desachy et 
al.), and ≥ 300mL (Montejo et al.). These studies did not evaluate variable 
GRVs, and the outcomes associated with these GRVs were incidental findings. 
Variable GRVs were not examined independently by the researchers, and any 
interpretations related to the findings have an associated risk of bias (Parker, 
2008).  
 
Mentec et al.‟s (2001) prospective study confirmed that, with the earlier 
commencement of enteral nutrition in critically ill patients, and a thrust to 
prevent inappropriate cessation of feeding, it becomes even more important to 
monitor tolerance. Their study found high GRVs were an early indicator of 
upper digestive intolerance. This intolerance was associated with a higher 
incidence of nosocomial pneumonia, longer ICU stay, and a higher ICU 
mortality. The potential risk for the patient was related to either a GRV of 150 - 
500mL twice consecutively, or a GRV > 500mL. However, the participants in 
Mentec et al.‟s study were predominantly admitted with a medical diagnosis, 
which would potentially reduce the study‟s generalisability to the general ICU 
population. Furthermore, the potential implications for clinical practice related 
to the association of high GRVs with early indication of upper digestive 
intolerance identified in this study is incongruent with the study results of 
Kompan et al. (2004). These authors found that early enteral nutrition reduces 
upper intestinal intolerance and nosocomial pneumonia in the critically ill. 
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External validity 
 
This systematic review will now be discussed with respect to its external 
validity. The primary strengths of this systematic review are related to its 
methodological clarity and potential for repeatability. Limitations included the 
need for this systematic review to have a single reviewer, appraiser and 
reporter of the literature identified in the search strategy, aspects which may 
have compromised the external validity of this systematic review. To enhance 
validity and reliability, a further reviewer would have been sought if possible. 
This may have facilitated increased rigour related to the search strategy, 
inclusion and exclusion criteria, critical appraisal, and the grading of quality 
level for evidence. It is possible that the lack of a second reviewer may have 
allowed bias within this systematic review. There is also the possibility that 
relevant studies may not have been identified during the search strategy, 
despite the comprehensive search conducted by the author. This potential for 
bias may have been increased by the exclusion of unpublished research, and 
the absence of hand journal searching. A further limitation may be the 10 year 
timeframe applied to the inclusion criteria. 
 
Comparisons with other literature 
 
The results of this systematic review were not comparable with other reviews 
(Bourgault et al., 2007; Bowman et al., 2005; Cerra et al., 1997; Edwards & 
Metheny, 2000; Kattelmann et al., 2006; McClave et al., 2002; McClave & 
Snider, 2002; Parrish & McCray, 2003). Unlike other reviews, no 
recommendation for a definitive GRV is made in this systematic review due to 
the lack of strong evidentiary support for one GRV over another. However like 
other literature, the inconsistencies in the management of GRVs that contribute 
to inadequate enteral nutrition delivery were highlighted (Marshall & West, 
2006; McClave & Snider, 2002; Parrish & McClave, 2008). 
 
This discussion provided a summary of the main findings of the systematic 
review related to the outcome measures of caloric requirements met and 
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adverse events, including vomiting or emesis, regurgitation, frequency of 
aspiration and total intolerance episodes. These results have been considered in 
light of wider research, and their relevance has been applied to the review 
questions. The quality of evidence has been addressed in a discussion of 
potential biases in the review process. The next chapter presents the possibility 
for application to practice, and discusses dissemination of the results of this 
systematic review. Avenues for future research are proposed.   
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CHAPTER 7 CONCLUSION 
 
Chapter six provided a summary of the results, while discussing wider 
literature. Applicability of the evidence was addressed, and internal and 
external validity of this systematic review was considered. Chapter seven 
provides a discussion of applicability to practice, dissemination of the results of 
this review, and future opportunities for research. 
 
Application to practice 
 
The results of this systematic review have implications for practice. There is 
insufficient evidence to support the use of one particular GRV over another, or 
to change current practice related to accepting one GRV over another. This 
paucity of evidence leaves few options. One unsatisfactory, but obvious, option 
is to judiciously draw from the recommendations of the wider literature, 
including the professional groups and reviews, until further research provides 
more evidence. The impact of needing to be informed by recommendations 
from these professional groups (summarised in the background chapter), 
highlighted that strong, methodologically sound evidence, sought in this 
systematic review was not identified, and hence no practice changes are 
recommended. Despite the lack of firm recommendations, the purpose of this 
systematic review was to inform practice. In light of the findings, a 
considerable disparity and inconsistency in management of GRVs remains. 
 
The use of one GRV over another is a practice largely based on ritual and 
tradition, and is not supported by rigorous evidence. This systematic review 
benefits from a rigorous methodology used to answer the research question. 
Using the evidence-base and implementing research into practice requires 
strong, methodologically sound evidence (Kitson, Ahmed, Harvey, Seers, & 
Thompson, 1996). Implementation also requires carefully planned 
interventions including education, audit and change management strategies. 
Kitson et al. suggest that, whether an inductive or deductive approach, 
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involving staff in the change process and acting on contextual implications is 
essential to the success of the implementation process.  
 
There is the potential to learn from these findings, and inform practice by 
working together as a united MDT, and to achieve consistency in the existing 
management of GRVs. Of benefit would be a consistent team approach, which 
is regularly reviewed and updated with advances in the evidence-base. The 
effective dissemination of this knowledge promoting rigorous processes may 
improve patient care. Furthermore, MDT questions, such as the question that 
provoked this systematic review, would have had a readily available answer. 
An added benefit of establishing this shared MDT approach is that advances in 
knowledge would be more readily disseminated, integrated, and applied to 
practice. 
 
Dissemination 
 
Words alone do not provoke action; an incentive to influence attitude, 
knowledge and behaviour supports dissemination of information (Lomas, 
1991). The results of this systematic review have not instigated a practice 
change related to specific GRVs in the enterally fed adult ICU patient; however 
the results do inform clinical practice. Methods for dissemination and 
utilisation of research may include a structured framework, such as that 
proposed by Dobbins et al. (2002). Their framework includes contextual 
influences such as the individual, organisation, environment and innovation, 
and presents a staged process of dissemination incorporating knowledge, 
persuasion, decision, implementation, and confirmation. 
 
With a structured approach to the dissemination of the findings of this 
systematic review, publication of the results is just one step in a strategy to 
enhance patient outcomes through more effective, consistent, and 
multidisciplinary management of GRVs. Publication would be supplemented 
with developing the knowledge base of clinicians through one-on-one personal 
contact with related MDT members, audit, and feedback. This would be 
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followed by supporting the initiative into practice, adopting Dobbins et al.‟s 
strategy for research dissemination and utilisation. There is clear potential to 
enhance strategies surrounding the delivery and management of enteral 
nutrition and GRVs in the ICU adult patient. Further research would be of 
significant benefit in addressing the delivery and management of enteral 
nutrition and GRVs. 
 
Future research 
 
As demonstrated in this systematic review, there remain opportunities for 
future research related to the management of GRVs in the enterally fed 
critically ill patient, and achieving optimal volumes of nutrition delivered. For 
example, an adequately sized, methodologically sound, randomised controlled 
trial comparing both the long-term and short-term outcomes associated with 
accepting a GRV of 500mL (the highest proposed GRV from the guidelines 
and reviews evaluated) versus 200mL (the current average recommendation 
from the guidelines and reviews evaluated) would be beneficial. Alternatively, 
there is the potential consideration that GRVs are not an effective marker for 
enteral nutrition tolerance or intolerance and thus, of benefit would be to begin 
to explore other areas to enhance the delivery of enteral nutrition and to 
mitigate risk. One example of an area to investigate further is commencing 
enteral nutrition at higher infusion rates, or at goal rate. It is clear that there 
remain opportunities to enhance delivery of nutrition to the critically ill patient, 
and this research project provides the first step in that journey. 
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BACKGROUND 
 
There are inconsistencies between accepted gastric residual volumes (GRVs) in 
the enterally fed adult ICU patient identified both in the literature (Bourgault et 
al., 2007; Bowman et al., 2005; Cerra et al., 1997; Kattelmann et al., 2006; 
Keithley & Swanson, 2004; Marshall, 2005; McClave et al., 2002; McClave & 
Snider, 2002; Metheny, 2008; Parrish & McClave, 2008; Parrish & McCray, 
2003; Pinilla et al., 2001; Zaloga, 2005), and in the recommendations of 
clinical practice guidelines (American Gastroenterological Association, 1994; 
American Society for Parenteral and Enteral Nutrition Board of Directors & 
The Clinical Guidelines Task Force, 2002; Cerra et al., 1997; Critical Care 
Nutrition, 2007; Dietitians Association of Australia Nutrition Support Interest 
Group, 2007; Heyland et al., 2004; Heyland et al., 2003; Jolliet et al., 1998; 
McClave et al., 2002; National Collaborating Centre for Acute Care, 2006; 
Stroud et al., 2003). The recommended acceptable GRVs vary widely, from 
150mL to 500mL. Furthermore, the use of GRVs as a marker for tolerance 
remains contentious and is related to the lack of reliability in the measure 
(Bochicchio et al., 2006; Chang et al., 2007; Kompan et al., 2004; Landzinski 
et al., 2008; Lin & Van Citters, 1997; MacLaren et al., 2008; McClave et al., 
2005; McClave & Snider, 2002; Metheny, 2008). Various interventions are 
recommended within this literature related to the specified GRVs, including 
cessation of enteral nutrition, reducing enteral nutrition, continuing enteral 
nutrition with careful assessment, implementing alternative strategies to reduce 
potential risk of aspiration, and introducing prokinetics. These 
recommendations were supported from sources ranging from a single expert 
opinion or a single randomised controlled trial, to a systematic review of 
several research trials. What is highlighted by this literature review is the 
potential scope for a systematic review to inform this topic more effectively 
than the existing literature. 
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Description of the intervention 
 
Marshall and West‟s (2004) literature review identified that existing 
management of enteral feeding resulted in insufficient delivery of nutrition. 
They concluded that enteral feeding protocols had improved nutritional intake, 
but there was wide scope for further research, particularly in the areas of 
nursing assessment and management of feeding intolerance. One feature of an 
enteral nutrition protocol was recommendations related to timeliness of GRV 
measurements, and specified management strategies for GRVs greater or less 
than a stated volume. These recommendations were to increase, decrease, or 
cease the enteral nutrition infusion rate in response to the volume measured, 
which was thought to reflect patient tolerance or intolerance of the enteral 
nutrition (Bowman et al., 2005). 
 
Tolerance and intolerance of enteral nutrition in the critically ill patient has 
wide variation in definition. Indicators of intolerance to enteral nutrition were 
defined as vomiting, abdominal distension, diarrhoea and high GRV (Kozar et 
al., 2002). For the purpose of this systematic review, GRVs will be addressed 
further. Measuring GRVs involves using a large syringe fitted to the feeding 
tube and aspirating to check the remaining gastric contents of the stomach 
(Arbogast, 2002). The historical premise for measuring a GRV, as highlighted 
by McClave and Snider (2002), was that large residual volumes have been 
thought to indicate gastric intolerance to enteral feeding, a potential for 
vomiting and aspiration, and ultimately a risk for aspiration pneumonia. 
Conversely, based on these assumptions, low GRVs would suggest enteral 
nutrition tolerance and a minimal risk of aspiration (McClave & Snider). 
However, accepting a GRV too low may subject the patient to underfeeding, 
and hence their nutritional needs not being met. 
 
The underlying assumption that the stomach has a fixed volume capacity, and 
measurement of the volume of stomach contents enables prediction of potential 
overflow into the oesophagus and increased aspiration risk, has been dismissed 
as inherently flawed (McClave & Snider, 2002). This premise for aspiration 
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risk assessment may be further undermined by Metheny et al.‟s (2008) 
descriptive study which found that of their 206 participants, 92.7% had at least 
one tracheal secretion positive for pepsin. This was deemed as a proxy for the 
aspiration of gastric contents by Metheny et al. Although this percentage of 
aspiration increased as GRVs increased, even patients who had a GRV between 
0-50mL had 33.7% positive pepsin assays (Metheny et al.). 
 
Parrish and McClave (2008) suggest that the practice of assessing GRVs 
developed from a set of assumptions that reflect a paucity of scientific data. 
These assumptions include that: the practice of assessing GRVs will identify 
abnormal gastric emptying, elevated GRVs are a direct result of delayed gastric 
emptying, the GRV evaluates retention of enteral formula, accumulation of 
enteral nutrition in the stomach leads to aspiration, and aspiration of gastric 
contents results in pneumonia. According to Parrish and McClave, the ultimate 
impact of these assumptions was that enteral nutrition was frequently 
discontinued inappropriately based on the practice of assessing GRVs. 
Furthermore, they suggest that the use of GRVs has never been shown to 
improve patient outcome or reduce complications and thus there is little point 
in standardising this practice. They have highlighted the poor sensitivity, 
specificity and accuracy in the GRVs correlation to gastric emptying or 
predicting outcomes. Despite this, high gastric residual volumes were 
identified as one of the primary reasons for discontinuing enteral nutrition 
(McClave et al., 1999), and required significant nursing time (Mentec et al., 
2001). One recent prospective observational study in the United States of 
America (USA) suggested removing the measurement of GRV from enteral 
nutrition protocols to improve delivery (O'Meara et al., 2008). This was 
contested by Metheny (2008) who, critiques O'Meara et al.‟s study. 
 
Metheny (2008) suggested that O‟Meara et al.‟s (2008) data may not be 
reliable due to the possibility of the participants „small-bowel tubes‟ to have 
been dislocated upward into the stomach, purporting that this may have 
accounted for the unusually high residual volumes found in the study. Metheny 
strongly disagreed with O'Meara et al.‟s recommendation to abandon GRV 
measurements and argued, citing two studies (Mentec et al., 2001; Metheny et 
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al., 2008), that GRV assessment may identify patients at high risk for 
aspiration and aspiration-related pneumonia. Hence, the assessment of GRVs 
in conjunction with a clinical assessment of tolerance, in the enterally fed 
critically ill patient, may still be appropriate until more data is available 
recommending other measures (Parrish & McClave, 2008). 
 
How the intervention might work 
 
It is essential to balance important benefits against important harms when 
administering enteral nutrition and this is demonstrated in the objectives of this 
systematic review. The objectives seek the potential benefits of the delivery of 
optimal caloric intake by identifying the best evidentiary GRV. This is 
balanced against the complications related to accepting a GRV too high or too 
low, potentially predisposing the adult ICU patient to harm. 
 
OBJECTIVES 
 
The aim of this systematic review is to investigate gastric residual volumes in 
the gastrically fed adult ICU patient related to the primary outcome measures 
indicative of: accepting a specified GRV too high, and hence placing the 
patient at risk of vomiting, regurgitation, aspiration of gastric contents and 
potentially aspiration pneumonia; or accepting a specified GRV too low, and 
hence not achieving caloric needs, potentially placing the patient at risk of 
malnutrition and increased morbidity. This systematic review sought to answer 
the research question: what is the maximum GRV to accept and continue the 
delivery of enteral nutrition in the ICU adult patient? 
 
METHODS 
 
The review will follow the following protocol. 
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Criteria for considering studies for this review 
 
Types of Studies 
 
Four types of studies will be eligible for inclusion: randomised controlled trials 
with random or quasi-random allocation of subjects to intervention and control 
groups; case controlled studies; cohort studies; and observational studies. 
 
Types of Participants 
 
Studies of participants aged 16 years or over, in the critical care or intensive 
care unit, and delivered enteral nutrition by a nasogastric or orogastric tube, 
will be included. 
 
Types of Interventions 
 
Studies that compared two or more GRVs will be included. 
 
Types of Outcome Measures 
 
Eligible studies will have outcome measures including caloric requirements 
met, or adverse events including: vomiting (or emesis), regurgitation, or 
aspiration. 
 
Search Methods for Identification of studies 
 
The databases to be used in the search include: The Cochrane Library; 
CINAHL Plus with Full Text (EBSCO host via helicon); AMED, Ovid 
Nursing Full Text plus, EMBASE, CDSR, ACP Journal Club, DARE, CCTR, 
CLCMR, CLTA, CLEED, OVID MEDLINE (R) (Ovid SP); Proquest via 
helicon (advanced search); Pubmed via helicon (limits “all adult”, “humans”, 
“abstract”, “title”); and all EBM reviews. The key search terms will include: 
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gastric residual‟, „gastric aspirate‟, or „residual volume‟; „enteral nutrition‟, 
„gastric feeding‟, „nutrition‟ or „tube feeding‟; and „intensive care‟, „ICU‟ or 
„critically ill‟. The search will be limited to research published within the time 
period of 1998-2008 (a 10 year period), to obtain the most recent evidence 
available at the date of this review. 
 
Searching Other Resources 
 
Parenteral and enteral nutrition association websites including: American 
Society for Parenteral and Enteral Nutrition (ASPEN), Australian Society for 
Parenteral and Enteral Nutrition (AUSPEN), European Society for Parenteral 
and Enteral Nutrition (ESPEN), British Association of Parenteral and Enteral 
Nutrition (BAPEN), Canadian Parenteral and Enteral Nutrition Association, 
South African Society for Parenteral and Enteral Nutrition, will also be 
searched. Critical care websites to be searched will include the Joint Faculty of 
Intensive Care Medicine (JFICM) and European Society of Intensive Care 
Medicine (ESICM). The computer search will be supplemented by citation and 
author review of the articles selected and search of the grey literature including 
unpublished thesis and government documents. These will be searched for 
further relevant literature. 
 
Data Collection and Analysis 
 
Selection of Studies 
 
In accordance with the defined inclusion criteria, titles and abstracts will be 
reviewed for obviously irrelevant reports, taking care to be over-inclusive at 
this stage. Included in the title and abstract review will be primary studies from 
the past 10 years (1998 to 2008) that addressed: specifically gastric residual 
volumes; factors impeding delivery of enteral nutrition; tolerance or 
intolerance of enteral nutrition; and risk factors related to provision or delivery 
of enteral nutrition. 
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All primary studies identified in the abstract review that would potentially 
compare two or more GRVs in the enterally fed ICU adult patient will be 
obtained in full-text or portable document format (PDF). The full-text studies 
or PDFs will then be examined for compliance with the eligibility criteria. 
These final included studies will then be critically appraised. 
 
For any uncertainty related to acceptability of the study, the full text of the 
citation will be obtained for further evaluation. Following review, the full texts 
of eligible abstracts will then be re-reviewed by the author and justification for 
excluding studies at this stage will be documented. 
 
Data Extraction 
 
A data extraction form was developed by the author for the review which 
demarked characteristics of the included studies. This is displayed in Table 1. 
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Table 1. Data extraction form 
 
DATA EXTRACTION FORM 
STUDY ID  
REVISION DATE  
REVIEWER ID  
NOTES 
 
 
 ELIGIBLE FOR INCLUSION (tick 
appropriate box) 
 YES NO UNCLEAR 
TYPE OF STUDY 
Randomised controlled trial/Case 
controlled study/Cohort 
study/Observational study 
   
TYPE OF PARTICIPANTS 
Adult ICU patients 
   
TYPE OF INTERVENTION 
Comparison of 2 or more GRVs 
   
TYPE OF OUTCOME 
MEASURE (one or more) 
1. Caloric requirements achieved 
2. Adverse events (one or more) 
a) vomiting (or emesis) 
b) regurgitation 
c) aspiration 
   
Sample size  
Participant demographics 
 
 
Methods 
 
 
Reported outcomes 
 
 
Comments 
 
 
Level of Evidence (GRADE)  
 
*Guided by the recommendations of: Higgins JPT, Deeks JJ (editors). Chapter 
7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), 
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 
(updated September 2008). The Cochrane Collaboration, 2008. Available from 
www.cochrane-handbook.org. 
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Quality Assessment of Included Studies 
 
To facilitate quality assessment of the included studies the author plans to 
independently assess the quality of randomisation of included studies using the 
Cochrane Collaboration guideline (Higgins & Altman, 2008). 
Recommendations related to: allocation; blinding; follow-up and exclusions; 
selective reporting; and other potential sources of blinding. This assessment 
tool is depicted in Table 2, which summarises the framework for assessing the 
risk of bias. 
 
Table 2. Risk of bias assessment tool* 
 
Domain Description Reviewers 
judgement 
Sequence generation   
Allocation concealment   
Blinding of participants, 
personnel and outcome 
assessors 
  
Incomplete outcome 
data  
  
Selective outcome reporting   
Other sources of bias   
 
*Adapted from Reeves, B., Deeks, J., Higgins, J., & Wells, G. (2008). 
Including non-randomized studies. In J. Higgins & S. Green (Eds.), Cochrane 
Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated 
September 2008): The Cochrane Collaboration. 
 
This framework would not be appropriate for non-randomised controlled trials, 
so the “Strengthening the Reporting of Observational Studies in 
Epidemiology” (STROBE) guide (von Elm et al., 2007), which provides a 
checklist of items that should be addressed in reports of observational studies, 
was adapted to appraise the quality of non-randomised controlled trials and is 
summarised in Table 3. 
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Table 3. Risk of bias assessment tool for a descriptive observational study*  
 
 Evidence  Reviewers decision 
(criteria met / not 
met) 
Title and abstract   
Introduction   
Background/rationale   
Objectives   
Methods   
Study design    
Setting   
Participants   
Variables   
Data sources/ 
Measurement 
  
Bias   
Study size   
Quantitative variables   
Statistical methods   
Results   
Participants   
Descriptive data   
Outcome data   
Main results   
Other analyses   
Discussion   
Key results   
Limitations   
Interpretation   
Generalisability   
Other information   
Funding   
 
*Adapted from von Elm, E., Altman, D., Egger, M., Pocock, S., Gotzsche, P., 
& Vandenbroucke, J. (2007). The strengthening the reporting of observational 
studies in epidemiology (STROBE) statement: Guidelines for reporting 
observational studies. Lancet, 370, 1453-1457. 
 
Levels of Evidence, Error and Bias 
 
Assigning a level of evidence, for the purpose of this systematic review, will be 
to facilitate identifying the quality and strength of the research methods used in 
the studies reviewed (Melnyk, 2004). The Cochrane Collaboration (Reeves et 
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al., 2008) outline the Grades of Recommendation, Assessment, Development 
and Evaluation (GRADE) approach to guide appropriation of a level of quality 
to a body of evidence. The GRADE approach is summarised in Table 4. 
 
Table 4. Cochrane’s levels of quality of a body of evidence in the GRADE 
approach* 
 
Underlying methodology Quality rating 
Randomised trials; or double-upgraded observational 
studies. 
High 
Downgraded randomised trials; or upgraded 
observational studies.  
Moderate 
Double-downgraded randomised trials; or 
observational studies.  
Low 
Triple-downgraded randomised trials; or downgraded 
observational studies; or case series/case reports. 
Very low 
 
*Adapted from Reeves, B., Deeks, J., Higgins, J., & Wells, G. (2008). 
Including non-randomized studies. In J. Higgins & S. Green (Eds.), Cochrane 
Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated 
September 2008): The Cochrane Collaboration. 
 
Ethical Considerations 
 
For this systematic review, it is likely conventional ethics approval will not be 
required as there are no human subjects. However, there is still the ethical 
responsibility to identify and critically appraise results accurately. This 
responsibility required an accurate process related to both the inclusion and 
exclusion criteria for studies, and also to the critical appraisal of the studies. 
Ideally, in a systematic review, more than one reviewer would participate in the 
process of research study inclusion and exclusion, quality assessment, and data 
extraction to facilitate reliability and validity by avoiding individual bias 
(Higgins & Altman, 2008; Roe, 2007). The nature of this research project, as 
an independent research thesis, meant the review will be conducted by a single 
author and reviewer. The implication of the author as the sole reviewer 
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increases the risk of bias in this systematic review and is identified as one of 
the limitations. 
 
To address this potential limitation and promote reliability and validity, the 
research process will be documented in detail in this thesis. All studies 
reviewed and critically appraised, both included and excluded, will be 
provided. A rationale for those studies excluded will be provided. Specific 
criteria have been identified for systematic reviews, and has been published on 
the National Institute for Health and Clinical Excellence website (Sander & 
Kitcher, 2006). These criteria, deemed of priority in the production of a 
systematic review of quality, included: search strategy; data synthesis; focussed 
question; study inclusion and exclusion criteria; study quality; data extraction; 
and study selection assessment. The Cochrane Collaboration and Cochrane 
systematic reviews have been exemplified throughout systematic review 
literature (Roe, 2007; Stevens, 2001). The critical appraisal process for this 
systematic review was adapted from the Cochrane systematic review 
framework (Higgins & Altman, 2008) and the STROBE guideline (von Elm et 
al., 2007). This provided both clarity and validated tools to ensure accuracy in 
the critical appraisals. Moher et al. (1995) have investigated checklists and 
scales that assist in the assessing and reporting of randomised controlled trials. 
 
Several shortcomings in checklists and scales for the assessment and reporting 
of randomised controlled trials have been identified by Moher et al. (1995). 
Jadad et al. (1996) described the development of a tool to assess randomised 
controlled trials for quality, and the impact of rater blinding on the quality 
assessment. Authors found that blinded assessments of randomised controlled 
trial were significantly lower and more consistent than open assessments. A 
blinded approach to appraisal of the included studies would have been optimal 
for this systematic review to enhance consistency and minimise potential bias. 
The nature of this research project, as previously identified, requires it to be 
conducted by a single author and reviewer. In effect, it would not possible to 
blind the reviewer in the appraisal process which further potentiates the risk of 
bias in this systematic review. 
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Data Analysis 
 
Dichotomous data will be presented as relative risk, and to be calculated as an 
overall relative risk with a 95% confidence interval. Sources of potential 
heterogeneity will be assessed according to the criteria outlined by Deeks et al. 
(2008). Firstly, clinical heterogeneity will be determined by considering the 
specific interventions and patient characteristics. If the studies are clinically 
homogenous, methodological heterogeneity will be determined by considering 
the use of blinding, allocation concealment, and outcome measures. Should the 
studies be both clinically and methodologically homogenous, statistical 
heterogeneity will be determined by assessment of outcome measures with 
subgroup or sensitivity analyses using the chi-squared test, which will be 
included in forest plots (Deeks et al.). This test will measure whether identified 
differences in results could be attributable to chance alone. Inconsistency will 
be measured using I-squared (I
2
) to identify whether variability in effect may 
be due to heterogeneity or purely chance (Deeks et al.). 
If the data from the randomised controlled trials are of sufficient quality and 
generalisability, they will be combined in a meta-analysis to provide a pooled 
effect estimate. Sensitivity will be maximised by excluding unpublished studies 
and by the critical appraisal of all included studies. Assessment for publication 
bias will be through the use of funnel plots if sufficient randomised controlled 
trials are identified. 
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Appendix 2. Risk of bias assessment tool* 
 
Domain Description Reviewers’ judgement 
Sequence generation   
Allocation concealment   
Blinding of participants, 
personnel and outcome assessors 
  
Incomplete outcome 
data  
  
Selective outcome reporting   
Other sources of bias   
 
*Adapted from Reeves, B., Deeks, J., Higgins, J., & Wells, G. (2008). 
Including non-randomized studies. In J. Higgins & S. Green (Eds.), Cochrane 
Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated 
September 2008): The Cochrane Collaboration. 
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Appendix 3. Risk of bias assessment tool for a descriptive 
observational study* 
 
 Evidence  Reviewers’ decision 
(criteria met / not 
met) 
Title and abstract   
Introduction   
Background/rationale   
Objectives   
Methods   
Study design    
Setting   
Participants   
Variables   
Data sources/Measures   
Bias   
Study size   
Quantitative variables   
Statistical methods   
Results   
Participants   
Descriptive data   
Outcome data   
Main results   
Other analyses   
Discussion   
Key results   
Limitations   
Interpretation   
Generalisability   
Other information   
Funding   
 
*Adapted from von Elm, E., Altman, D., Egger, M., Pocock, S., Gotzsche, P., 
& Vandenbroucke, J. (2007). The strengthening the reporting of observational 
studies in epidemiology (STROBE) statement: Guidelines for reporting 
observational studies. Lancet, 370, 1453-1457. 
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Appendix 4. Cochrane’s levels of quality of a body of evidence 
in the GRADE approach* 
 
Underlying methodology Quality rating 
Randomised trials; or double-upgraded 
observational studies. 
High 
Downgraded randomised trials; or 
upgraded observational studies.  
Moderate 
Double-downgraded randomised trials; 
or observational studies.  
Low 
Triple-downgraded randomised trials; 
or downgraded observational studies; 
or case series/case reports. 
Very low 
 
*Adapted from Reeves, B., Deeks, J., Higgins, J., & Wells, G. (2008). 
Including non-randomized studies. In J. Higgins & S. Green (Eds.), Cochrane 
Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated 
September 2008): The Cochrane Collaboration. 
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Appendix 5. Data extraction form 
 
DATA EXTRACTION FORM 
STUDY ID/REVIEWER ID  
REVISION DATE  
 ELIGIBLE FOR INCLUSION  
 YES NO UNCLEAR 
TYPE OF STUDY 
Randomised controlled trial/Case 
controlled trial/Cohort 
study/Observational study 
   
TYPE OF PARTICIPANTS 
Adult ICU patients 
   
TYPE OF INTERVENTION 
Comparison of 2 or more GRVs 
   
TYPE OF OUTCOME 
MEASURE (one or more) 
1. Caloric requirements achieved 
2. Adverse events (one or more) 
a) vomiting (or emesis) 
b) regurgitation 
c) aspiration 
   
Sample size  
Participant demographics 
 
 
Methods 
 
 
Reported outcomes 
 
 
Comments  
Level of Evidence (GRADE)  
 
*Guided by the recommendations of: Higgins JPT, Deeks JJ (editors). Chapter 
7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), 
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 
(updated September 2008). The Cochrane Collaboration, 2008. Available from 
www.cochrane-handbook.org. 
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Appendix 6. Search sources, terms and numbers retrieved 
 
Source searched Search strategy Hits retrieved 
Cinahl Plus with Full 
Text (EBSCOhost via 
helicon) (4/08/2008). 
1. Enteral nutrition 
AND critical care. 
2. Gastric residual. 
No limiters used. 
1. 274 
2. 47 
AMED, Ovid Nursing 
Full Text plus, 
EMBASE, CDSR, ACP 
Journal Club, DARE, 
CCTR, CLCMR, CLTA, 
CLEED, OVID 
MEDLINE (R) (Ovid 
SP) (20/09/2008). 
1. Gastric residual.mp. 
[mp = ab, hw, kw, ti, 
ot, sh, tn, dm, mf, tx, 
ct, nm]. 
No limiters used. 
1. 272 
Proquest (advanced 
search) (via helicon)  
1. Gastric residual. 
(21/09/2008). 
2. Prevention of 
aspiration 
pneumonia. 
(21/09/2009). 
3. Gastric aspirate. 
Limiters: „citation and 
abstract‟. 
1. 134 
2. 48 
3. 87 
Pubmed (limits “all 
adult”, “humans”, 
“abstract”, “title”) 
(4/08/2008) (Pubmed via 
helicon). 
1. Gastric residual. 
Limiters: „all adult, 
humans, abstract, title‟. 
1. 49 
Proquest (02/03/2009) 1. Gastric residual 
No limiters 
1. 53 
Pubmed (02/03/2009) 1. Gastric residual 
No limiters used 
1. 112 
Cinahl Plus with full text 1. Gastric residual 1. 49 
The Cochrane Library 1. Gastric residual 1. 178 
Amed, all EBM reviews, 
EMBASE all years, 
Medline 1996-current) 
(Ovid SP) 
1. Gastric residual 
Removed duplicates 
1. 143 
 
Allied and Complementary Medicine (Amed) 1985 - September 2008, EBM 
Reviews - ACP Journal Club 1991 - August 2008, EBM Reviews – Cochrane 
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Central Register of Controlled Trials 3
rd
 Quarter 2008, EMB Reviews – 
Cochrane Database of Systematic Reviews 3
rd
 Quarter 2008, EBM Reviews – 
Cochrane Methodology Register 3
rd
 Quarter 2008, EMB Reviews – Database 
of Abstracts of Reviews of Effects 3
rd
 Quarter 2008, EBM Reviews – NHS 
Economic Evaluation Database 3
rd
 Quarter 2008, EMB Reviews – Health 
Technology Assessment 3
rd
 Quarter 2008, Ovid MEDLINE(R) 1996 to Present 
with Daily Update, Ovid Nursing Full Text Plus 1950 to September Week 1 
2008. 
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Appendix 7. Detailed characteristics of excluded studies 
 
Study & 
Method 
Participants Intervention Outcome 
measures 
Bochicchio 
et al. (2006) 
 
Prospective 
study 
Setting: USA  
 
n = 57 patients were 
enrolled. 
 
No exclusion criteria 
reported. 
 
Demographics: 42 
men, a mean age of 
37 +/- 12 years. The 
mean injury severity 
score was 24 +/- 10, 
38 patients had an 
isolated traumatic 
brain injury induced 
into barbiturate 
coma due to 
refractory 
intracranial 
hypertension. 
 
No sample size 
calculations 
reported. 
Non-
interventional 
1. Tolerance to 
enteral nutrition 
Davies et al. 
(2002)  
 
Randomised 
prospective 
study 
Setting: Australia 
 
n = 73 ICU patients. 
 
Included: any patient 
expected to require 
nutritional and 
critical care support 
for at least 3 days. 
 
Excluded: unsuitable 
for passage of 
nasoenteral tube, 
already receiving 
nutritional support, 
expected to die 
within 48 hrs. 
 
Demographics:  
Group 1 (n = 39, 
gastric): mean age 
Two groups: 
1. Nasojejunal 
tube fed. 
2. Nasogastric 
tube fed. 
1. Demographics 
and admission 
diagnosis and 
APACHE II 
score 
2. Volume of 
enteral nutrition 
delivered, RV 
6hrly, time and 
reason for 
cessation of 
enteral 
nutrition, 
intolerance of 
enteral 
nutrition, ICU 
mortality rate, 
duration of 
enteral 
nutrition, time 
to reach target 
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Study & 
Method 
Participants Intervention Outcome 
measures 
53.5±2.9yrs, 24 men 
and 15 women, 
APACHE II score at 
admission 20.7±1.3 
and at randomisation 
18.6±1.1, 
mechanically 
ventilated 35. 
 
Group 2 (n = 34, 
jejunal): mean age 
55.7±3.63, 26 men 
and 8 women, 
APACHE II score at 
admission 20.4±1.5 
and at randomisation 
17.6±1.3, 
mechanically 
ventilated 31. 
 
Primary diagnoses 
for both groups were 
cardiogenic shock, 
septic shock/multiple 
organ failure, 
pneumonia/acute 
respiratory failure, 
liver 
disease/gastrointesti
nal tract illness, 
spinal cord injury, 
neurologic illness 
and multiple trauma. 
 
Sample size 
calculations 
conducted by the 
authors and were: 35 
participants with 
80% power and 5% 
significance. 
enteral nutrition 
rate 
3. Development 
of pneumonia, 
systemic 
inflammatory 
response 
syndrome, 
severe sepsis, 
septic shock, 
renal failure, 
gastrointestinal 
bleeding, 
diarrhoea, 
inadvertent 
removal of then 
NGT, NGT 
blockage, and 
any other 
adverse effects. 
Desachy et 
al. (2008) 
 
Open 
prospective 
randomised 
study 
Setting: USA 
 
n = 100 consecutive 
intubated and 
mechanically 
ventilated patients in 
medical/surgical 
Two groups: 
1. Commence 
early enteral 
nutrition 
gradually 
(gradual 
early enteral 
1. Calorie intake 
(delivered 
versus 
prescribed) 
2. Serious adverse 
events 
requiring 
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Method 
Participants Intervention Outcome 
measures 
ICUs. 
 
Demographics: 
Group 1 (n = 50, 
gradual early enteral 
nutrition). 
Group 2 (n = 50, 
immediate early 
enteral nutrition). 
 
69 men and 31 
women were 
enrolled; mean age 
was 61±16 yrs 
(range, 18-90 years). 
Admissions were 68 
medical, 11 surgical 
and 21 traumas. 
Mean SAPS II score 
was 41±14 (range 9-
83). Randomisation 
bias led to 
significantly more 
patients being 
admitted post-
surgery in the 
gradual group and 
more patients being 
admitted for trauma 
in the immediate 
optimal flow group. 
 
nutrition), or 
2. Commence 
enteral 
nutrition at 
optimal flow 
rate 
(immediate 
early enteral 
nutrition). 
enteral nutrition 
withdrawal 
(colectasia, 
suspected 
aspiration, 
regurgitation, 
vomiting) 
3. Tolerability of 
enteral nutrition 
(GRVs 
measured and 
diarrhoea). 
Elpern, 
Stutz, 
Peterson, 
Gurka, & 
Skipper 
(2004)  
 
Prospective 
descriptive 
study 
Setting: USA 
 
n = 39 medical ICU 
patients. 
 
Included: 18 years or 
older admitted 
during 3-month 
period of data 
collection and 
ordered to receive 
enteral nutrition. 
Excluded: those 
patients unlikely to 
stay in the ICU for a 
minimum of 48 hrs 
Non-
interventional 
1. Feeding 
protocol 
described, GRV 
< 150mL was 
considered 
acceptable to 
continue 
feeding in this 
study. 
2. Compare actual 
intake delivered 
with ordered 
energy intake to 
be delivered. 
3. Ascertain 
frequency, 
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Study & 
Method 
Participants Intervention Outcome 
measures 
or if they received 
any oral or 
parenteral feedings. 
Demographics: 54% 
of patients were 
men, the mean age 
was 60.6 years 
(range, 27-93 years), 
The mean APACHE 
II was 19.97 (range, 
9-33). Large-bore 
NGT were in place 
for 79% of feeding 
days, PEG tubes in 
14% and small-bore 
feeding tubes for 
7%. 
No sample size 
calculations 
reported. 
duration, and 
reasons for 
interruptions of 
feedings. 
4. Determine 
instances of 
feeding 
intolerance and 
complications 
related to 
feeding. 
Esparza et al. 
(2001)  
 
Prospective 
controlled 
trial 
Setting: USA  
 
n = 54 critically ill 
patients. 
 
Inclusion/exclusion 
criteria were not 
discussed. 
 
Demographics: 
Group 1 (n = 27, 
gastric): mean age 
50±17yrs, 17 men 
and 10 women, 
APACHE II score 
17.1±5.9, 
mechanically 
ventilated 25, SAPS 
10.1±3.7, and 
Glasgow Coma 
Score (GCS) 10±4. 
 
Group 2 (n = 27, 
transpyloric): mean 
age 45±14yrs, 20 
men and 7 women, 
APACHE II score 
15.8±4, 
Two groups: 
1. Gastrically 
fed patients. 
2. Transpyloric
ally fed 
patients. 
1. Study days, 
feed days, 
isotopic 
aspiration, 
average daily % 
of goal feed, 
death. 
2. Use of a 
motility agent, 
volume of feed, 
tube position, 
evidence of 
clinical or 
isotopic 
aspiration. 
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Method 
Participants Intervention Outcome 
measures 
mechanically 
ventilated 26, SAPS 
9.4±2.8, and GCS 
10±4. 
 
Primary diagnoses 
for both groups were 
pneumonia, sepsis, 
neurological, 
gastrointestinal 
bleeding, and liver 
disease. 
 
Sample size 
calculations 
conducted by the 
authors and were: 54 
participants with 
80% power and 5% 
significance. 
Fiaccadori et 
al. (2004)  
 
Prospective 
observational 
study 
Setting: Italy  
 
n = 247 patients (182 
with acute renal 
failure). 
 
Included: patients 
receiving enteral 
nutrition before 
transferral to the 
ICU or patients who 
were started on 
enteral nutrition in 
the ICU. 
 
Excluded: attending 
physicians 
established 
indications for 
enteral nutrition, 
choice of enteral 
nutrition route, and 
exclusion criteria. 
 
Demographics:  
Group 1 (N = 65, 
normal renal 
function): mean age 
Non-
interventional 
1. Measurements 
included: 
demographics, 
nutritional 
support, enteral 
nutrition-
related 
complications 
(gastrointestinal
, mechanical 
and metabolic), 
and compliance 
with enteral 
nutrition orders. 
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Study & 
Method 
Participants Intervention Outcome 
measures 
66.9yrs, 39 men and 
26 women, 
APACHE II score 
14.6, mechanical 
ventilation 23. 
 
Group 2 (N = 68, 
ARF not on renal 
replacement 
therapy): mean age 
70.9yrs, 42 men and 
26 women, 
APACHE II score 
21.1, mechanical 
ventilation 27. 
 
Group 3 (N = 114, 
acute renal failure on 
renal replacement 
therapy): mean age 
71.1yrs, 81 men and 
33 women, 
APACHE II score 
24.0, mechanical 
ventilation 47. 
 
No sample size 
calculations 
reported. 
Kearns et al. 
(2000)  
 
Prospective 
randomised 
controlled 
trial 
Setting: USA  
 
n = 44 intubated and 
ventilated patients 
requiring enteral 
nutrition in a 
medical ICU. 
 
Excluded: 
hypotension, 
abdominal surgery, 
pancreatitis, 
gastrointestinal 
bleeding, or ileus. 
 
Demographics:  
Group 1 (n = 21, SI): 
14 men and 7 
women, mean age 
Two groups: 
1. Gastric tube 
fed. 
2. Small 
intestine 
tube fed. 
1. The primary 
outcome 
measures were 
achievement of 
caloric goals 
and the 
incidence of 
VAP (process 
described). 
2. Secondary 
outcome 
measures 
included 
survival, 
duration of tube 
feeding, 
duration of the 
ICU and 
hospital stay, 
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Method 
Participants Intervention Outcome 
measures 
54±3yrs, APACHE 
score 22±2. 
 
Group 2 (n = 23, G): 
16 men and 7 
women, mean age 
49±4yrs, APACHE 
score 20±1. 
 
Primary diagnoses 
for both groups 
were: septic shock 
(6), pneumonia (6), 
cerebral vascular 
accident (4), and 
respiratory failure 
(4). 
 
Sample size 
calculations 
conducted by the 
authors and were: 20 
participants per 
group with 80% 
power and 5% 
significance. 
the number of 
feeding tubes 
placed, the 
incidence of 
gastrointestinal 
bleeding, 
feeding 
intolerance 
(defined as a 
GRV > 150mL, 
ileus or 
abdominal 
distension), the 
number of 
blood cultures, 
and days of 
diarrhoea 
(defined). 
Kompan, 
Vidmar, 
Spindler-
Vesel, & 
Pecar (2004) 
 
Prospective 
study 
Setting: Slovenia  
 
n = 52 patients 
 
Demographics:  
Group 1 (n = 27, 
early enteral 
nutrition) 
Group 2 (n = 25, 
delayed enteral 
nutrition) 
 
Multiply injured 
patients with an 
injury severity score 
of > 20. Only those 
patients who 
recovered from 
shock within 6hrs of 
admission to ICU 
were included. 
Admission 
Two groups: 
1. Intragastric 
tube feeding 
started 
immediately 
upon 
admission 
(early 
enteral 
nutrition 
group). 
2. Delayed 
feeding 
initiated 
more than 24 
hours after 
admission 
(delayed 
enteral 
nutrition 
group). 
1. Nosocomial 
infection 
(criteria 
defined). 
2. Upper digestive 
intolerance 
(criteria 
defined, GRV > 
200mL twice 
consecutively 
or vomiting). 
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measures 
diagnosis: 34 head 
injury, 25 chest 
injury, 50 skeletal 
trauma. 
 
No sample size 
calculations 
reported. 
Kortbeek et 
al. (1999)  
 
Randomised 
controlled 
trial 
Setting: Canada  
 
n = 80 adult 
ventilated trauma 
patients in an ICU. 
 
Excluded: disruption 
of gastrointestinal 
tract, traumatic 
pancreatitis, severe 
physiologic 
instability precluding 
transport for 
fluoroscopy, a 
prognosis considered 
to be hopeless, 
enrolment into 
another trial, prior 
initiation of enteral 
nutrition, and failure 
to enrol or initiate 
the trial within 72 
hrs of ICU 
admission. 
 
Demographics: 
Group 1 (n = 43, 
gastric): mean age 
34.7±15.7yrs, 34 
men and 9 women, 
ISS 30.0±11, 
APACHE II 
18.0±6.0, 34/43 had 
a head injury, 
median GCS was 6 
(range, 3-15). 
 
Group 2 (n = 37, 
duodenal): mean age 
33.6±17.5yrs, 28 
Two groups: 
1. Gastric 
feeding. 
2. Duodenal 
feeding. 
1. Nutritional 
assessment and 
administration 
calculations. 
2. Duration of 
stay and 
ventilator days. 
3. Mortality. 
4. Ventilator 
associated 
pneumonia. 
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men and 9 women, 
ISS 33±9.7, 
APACHE II 
18.0±7.4, 28/37 had 
a head injury, 
median GCS was 5 
(range, 3-15). 
 
A sample size 
calculation was 
reported but this 
sample size was not 
obtained. 
McClave et 
al. (1999) 
 
Prospective 
study 
Setting: USA  
 
n = 44 medical 
ICU/CCU enterally 
fed patients. 
 
Demographics: 44 
patients (mean age 
57.8yrs; 70% male); 
26 admitted to 
medicine/medical, 
12 surgery/trauma, 6 
neurosurgery. Two 
patients not 
mechanically 
ventilated. 
Underlying disease 
processes: chronic 
obstructive 
pulmonary disease 
(11%), diabetes 
mellitus (23%), 
malignancy (14%), 
Acute disease 
processes: trauma 
(27%), acute cardiac 
event (16%), 
neurological injury 
(45%).  
 
Excluded: patients 
who received any 
nutritional support 
by oral diet or by 
total parenteral 
Non-
interventional 
1. Volume of 
formula 
delivered 
/prescribed. 
2. Patient 
position. 
3. Presence 
/absence of 
blue dye in 
oropharynx. 
4. Frequency, 
duration and 
reasons for 
cessation of 
enteral 
nutrition. 
Avoidable 
cessations were 
defined.  
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measures 
nutrition or did not 
have a feeding tube 
placed initially after 
admission to the 
medical ICU/CCU. 
 
No sample size 
calculations were 
discussed by the 
authors. 
Mentec et al. 
(2001)  
 
Prospective 
observational 
study 
Setting: France 
  
n = 153 ICU patients 
with nasogastric tube 
feeding 
 
Demographics: 142 
patients were 
admitted with a 
medical diagnosis, 5 
surgical, 6 multi-
trauma. 47 had 
undergone recent 
surgery (18 had 
laparotomy, 7 
surgery for multiple 
trauma, 22 
miscellaneous). 86 
were men and 67 
were women with a 
mean age of 65±15 
and a mean SAPS II 
on admission of 
52±17. 830 days of 
enteral nutrition 
were monitored; 
median length of 
survey per patient 
was 4 days (range, 1-
20 days). 
 
No sample size 
calculations 
reported. 
Non-
interventional 
1. Complications 
of enteral 
nutrition 
2. Monitoring of 
patients for 
development of 
vomiting and 
nosocomial 
pneumonia 
until ICU 
discharge 
3. Patients status 
on ICU and 
hospital 
discharge 
Montejo 
(1999)  
 
Multicentre 
Setting: Spain 
 
n = 400 consecutive 
patients admitted to 
Non-
interventional 
1. Mean time of 
enteral nutrition 
2. Mean elapsed 
time from ICU 
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measures 
prospective 
cohort study 
the ICU and 
receiving enteral 
nutrition. 
37 ICUs 
participated, most 
(75%) in tertiary 
care centres. 400 
patients were 
enrolled. The 
primary diagnosis 
was a medical 
disease. 
  
Demographics: mean 
age 56.6yrs, 
APACHE II mean 
18.2 (range, 14-22), 
primary admitting 
diagnoses were: 264 
medical, 97 trauma, 
39 surgery. 
admission to 
start of enteral 
nutrition 
3. Administered 
versus 
prescribed 
enteral nutrition 
ratio calculated 
4. Gastrointestinal 
complications 
related to 
enteral 
nutrition, and 
their 
management 
were 
predefined then 
these variables 
were measured. 
 
Montejo et 
al. (2002)  
 
Prospective 
randomised 
multicentre 
trial 
Setting: Spain  
 
n = 101 critically ill 
patients who could 
receive early enteral 
nutrition for more 
than 5 days in the 
ICUs of 11 Spanish 
teaching hospitals. 
Inclusion: Patients 
who could receive 
early enteral 
nutrition for > 5 
days, > 18 years old, 
with no 
contraindications to 
enteral nutrition. 
 
Exclusion: 
anatomical 
disruptions of 
gastrointestinal tract, 
previous 
gastrointestinal 
surgery, or 
contraindication for 
enteral nutrition or 
Two groups: 
1. Nasogastric 
tube fed. 
2. Nasojejunal 
tube fed. 
1. Gastrointestinal 
complications. 
2. Efficacy of diet 
administration. 
3. Primary 
outcomes: 
mortality, 
length of stay, 
nosocomial 
pneumonia, 
MODS 
(multiple organ 
dysfunction 
score) at day 5, 
MODS at 
discharge. 
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gastric endoscopy. 
 
Demographics (no 
significant group 
differences):  
 
Group 1 (n = 51, 
gastric): 35 men and 
16 women, mean age 
59±18yrs, APACHE 
II score 19±7, 
MODS score 8±3. 
 
Group 2 (n = 50, 
jejunal): 36 men and 
14 women, mean age 
57±17yrs, APACHE 
II score 18±6, 
MODS score 8±3. 
 
Sample size 
calculations 
conducted by the 
authors and were: 
152 participants with 
80% power and 5% 
significance. 
Neumann & 
DeLegge 
(2002) 
 
Prospective 
randomised 
trial 
Setting: USA  
 
n = 60 medical ICU 
patients 
 
Included: ICU 
patients requiring 
enteral nutrition via 
gastric or small-
bowel tubes. 
 
Excluded: those 
patients with 
gastrointestinal 
obstruction, ileus, 
pancreatitis, 
documented 
gastroparesis, and an 
inability to gain 
informed consent. 
 
Two groups: 
1. Naso-gastric 
tube fed. 
2. Naso-small 
bowel tube 
fed. 
1. Methylene blue 
dye was added 
to enteral 
nutrition and 
residuals were 
checked 6hrly. 
2. Adverse 
outcomes were 
recorded, 
including: 
witnessed 
aspiration, 
vomiting, 
clinical or 
radiographic 
evidence of 
aspiration. 
3. Times of 
successful tube 
insertion, onset 
of feeding, 
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Demographics:  
Group 1 (n = 30, 
gastric): 15 men and 
15 women, mean 
patient age was 
58.1±15.4 years, 
predominant 
admitting diagnoses 
included pneumonia, 
sepsis, congestive 
heart failure, 
gastrointestinal 
bleeding and chronic 
obstructive 
pulmonary disease. 
 
Group 2 (n = 30, 
small bowel): 15 
men and 15 women, 
mean patient age 
was 59.6±15.3 with 
similar admitting 
diagnoses. 
 
No sample size 
calculations 
reported. 
achievement of 
goal rate, 
termination of 
feeding were 
recorded. 
Taylor, 
Fettes, 
Jewkes, & 
Nelson 
(1999)  
 
Prospective 
randomised 
controlled 
trial 
 
Setting: UK  
 
n = 82 patients. 
 
Inclusion criteria: 
presence of head 
injury requiring 
mechanical 
ventilation from day 
1; best Glasgow 
Coma Scale (GCS) 
score > 3 and at least 
one reactive pupil at 
some time during the 
first 24 hrs; older 
than 10 yrs; unable 
to take oral nutrition 
for more than 24 hrs, 
possible to 
commence enteral 
nutrition within 24 
Two groups: 
1. Standard 
enteral 
nutrition 
(gradually 
increased to 
goal rate). 
2. Enhanced 
enteral 
nutrition 
(started at 
feeding goal 
rate). 
1. Percentage of 
estimated 
energy and 
nitrogen 
requirements 
met and serum 
concentrations 
of proteins and 
IGF-1. 
2. Neurologic 
outcome 
(scoring system 
described). 
3. Incidences of 
infective and 
total 
complications 
during hospital 
stay up to six 
months. 
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Study & 
Method 
Participants Intervention Outcome 
measures 
hrs of injury. 
 
Exclusion criteria: 
recruitment into a 
concurrent drug 
study, gunshot head 
wound, presence of 
organ failure or 
potentially fatal 
disease before head 
injury, moribund 
state immediately 
after head injury, 
difficulty obtaining 
follow-up. 
 
Demographics:  
Group 1 (n = 41, 
standard, control): 
median age 28 yrs, 
ISS 25, APACHE II 
score 14, best GCS 
score 8. 
 
Group 2 (n = 41, 
enhanced, 
intervention): 
median age 34 yrs, 
ISS 26, APACHE II 
score 14, best GCS 
score 9. 
 
Disease severity and 
age were similar 
between groups but 
the intervention 
group had a higher 
GCS score and lower 
APACHE II scores, 
higher ISS score and 
age, and more 
patients with one 
fixed pupil at 24 hrs. 
 
Sample size 
calculations 
conducted by the 
authors and were: 82 
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Study & 
Method 
Participants Intervention Outcome 
measures 
participants with 
80% power and 5% 
significance. 
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Appendix 8. Risk of bias analysis for randomised controlled 
trials* 
 
 (Pinilla et al., 2001) (McClave et al., 2005) 
Possible bias Judgement Description Judgement Description 
Adequate 
sequence 
generation? 
Yes Computer-
generated table 
of random 
numbers was 
used with results 
provided in 
sealed 
envelopes. 
Unclear Authors state the 
“patients were 
randomized to 
one of two 
groups”, however 
this process is not 
described.  
Allocation 
concealment? 
Yes Computer-
generated table 
of random 
numbers was 
used with results 
provided in 
sealed 
envelopes. 
Unclear Authors state the 
“patients were 
randomized to 
one of two 
groups”, however 
this process is not 
described. 
Blinding? (of 
intervention 
vs control 
group) 
No Not done, may 
have been 
difficult with 
clinicians 
managing the 
GRVs. 
No Not done, may 
have been 
difficult with 
clinicians 
managing the 
GRVs. 
Incomplete 
outcome data 
addressed?  
Yes Data complete. Yes Data complete. 
Free of 
selective 
reporting? 
Yes All outcome 
measures were 
addressed in 
reporting. 
Yes All outcome 
measures were 
addressed in 
reporting. 
Free of other 
bias? 
Yes  Yes  
GRADE 
(Level of 
quality) 
Moderate Moderate 
 
*Adapted from Higgins, J., & Altman, D. (2008). Assessing risk of bias in 
included studies. In J. Higgins & S. Green (Eds.), Cochrane Handbook for 
Systematic Reviews of Interventions Version 5.0.1 (updated September 2008): 
The Cochrane Collaboration. 
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Appendix 9. Risk of bias analysis for descriptive observational 
study* 
 
(Metheny et al., 2008) Evidence  ?criteria met 
Title and abstract Study design and informative 
balanced summary provided. 
Met 
Introduction   
Background/ rationale Clear background and rationale. Met 
Objectives Study objectives described. Met 
Methods   
Study design  Clearly outlined. Met 
Setting Clearly described. Met 
Participants Inclusion demographics provided. Met 
Variables Percentage of aspiration 
according to changes in GRVs 
was described. 
Met 
Data 
sources/measurement 
Measurements were described. Met 
Bias There was no comment identified 
in the methods related to potential 
bias. 
Not met 
Study size There was no discussion of 
calculations regarding sample 
size. 
Not met 
Quantitative variables Groupings and analyses of the 
variables were described. 
Met 
Statistical methods Statistical methods and subgroup 
analysis was described. 
Met 
Results   
Participants Numbers of participants, tracheal 
secretion assays, and GRVs were 
provided. 
 Met 
Descriptive data Characteristics of study 
participants were provided. 
Met 
Outcome data Numbers of outcome events were 
provided. 
Met 
Main results Main results were provided with 
category boundaries for 
continuous variables. 
Met 
Other analyses Analysis of subgroups and 
sensitivity analyses were 
conducted. 
Met 
Discussion   
Key results Key findings were discussed. Met 
Limitations Identified study limitations were 
discussed. 
Met 
Interpretation The overall interpretation of the 
study results in the light of other 
research was discussed. 
Met 
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(Metheny et al., 2008) Evidence  ?criteria met 
Generalisability There was no discussion of the 
generalisability of the study 
results. 
Not met 
Other information   
Funding Financial disclosures were 
provided. 
Met 
GRADE (Level of 
quality)? 
Low 
 
*Adapted from von Elm, E., Altman, D., Egger, M., Pocock, S., Gotzsche, P., 
& Vandenbroucke, J. (2007). The strengthening the reporting of observational 
studies in epidemiology (STROBE) statement: Guidelines for reporting 
observational studies. Lancet, 370, 1453-1457. 
